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Summary 
 
Neural stem (progenitor) cells (NPCs) from fetal tissue are an ideal 
transplantable cell source. They divide rapidly, are able to generate cells of 
all three neural lineages and do not divide uncontrolled once transplanted 
into a host organism. To obtain large quantities of cells for transplantation 
strategies and to eliminate primary cell contaminations, long periods of in 
vitro cultivation are necessary.  
Mouse NPCs are a crucial tool for further investigations of neural 
stem cells because they make the employment of transgenic animals in vivo 
and cells in vitro possible. So far only short-term expanded fetal mouse 
NPCs have been shown to generate dopaminergic neurons and it is not 
clear whether this was due to differentiation or a result of increased survival 
of primary dopaminergic neurons. 
The aims of the thesis were to characterize mouse fetal NPCs, to 
establish the long-term expansion of fetal mouse NPCs and the generation 
of dopaminergic neurons in long-term expanded fetal mouse NPCs, to 
investigate the signaling mechanisms involved in the differentiation of mouse 
fetal NPCs towards the dopaminergic phenotype and to compare short and 
long-term expanded NPCs.  
Long-term expanded fetal mesencephalic NPCs could be grown 
under suspension and adherent culture conditions and showed self-
renewing capacity as well as markers typical for NPCs. They could be 
differentiated into the three major cell types of the nervous system, but 
suspension NPCs had a larger potential to generate neurons than 
adherently grown NPCs. Signaling cascades involved in this process were 
p38 and Erk1/2 mediated. Long-term expanded NPCs did not have the 
potential to generate neuronal sub-types. Importantly, they did not generate 
dopaminergic neurons. Mouse fetal NPCs from three different 
developmental stages (E10, E12, and E14) were employed but were not 
able to differentiate into dopaminergic neurons using factors known to 
stimulate in vitro dopaminergic specification.  
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When cultivated in vitro for short periods, fetal mesencephalic NPCs 
were able to generate dopaminergic neurons. By eliminating all primary Th-
positive neurons, FACS-sorting of NPCs proved a de novo generation of 
dopaminergic neurons, because after cultivation and differentiation of Th-
depleted cell solutions dopaminergic neurons were present in the culture. 
However, these newly generated neurons failed to incorporate BrdU, making 
a generation without cell division from precursors probable. The precursor 
population of short cultures differed from long-term expanded cultures 
suggesting an ‘aging’ effect of in vitro conditions. IL-1 was a potent inducer 
of the dopaminergic neuronal phenotype in short-term expanded in vitro 
cultures and was expressed in vitro as well as in vivo at E14.  
Several important conclusions concerning fetal mouse stem cell 
behavior could be drawn from the results of this work: 
Firstly, the results showed for the first time that in fetal mouse 
mesencephalic NPCs dopaminergic neurons differentiate from precursors 
without cell division, therefore consuming those progenitors. Therein fetal 
mouse NPCs differ significantly from rat and human NPCs or respond 
differently to the same in vitro conditions that need to be optimized for fetal 
mouse NPCs.  
Secondly, less committed precursors find appropriate conditions to 
proliferate but not to generate the more committed DA precursors that are 
able to generate dopaminergic neurons.  
The hallmarks of stem cells, self-renewal and multipotentiality, seem 
to be part of a delicate balance, that, when unsettled, goes in favor of one 
side without the possibility of returning to the previous status.  
Further research should focus on two coherent issues: the isolation of 
more pure populations of progenitors and the more precise characterization 
of progenitor populations to find out which in vitro conditions need to be 
provided to keep the balance between proliferation and differentiation 
potential. The knowledge gained about stem cells this way would help 
establish cell sources for transplantation strategies. 
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1. Introduction 
1.1 Stem cells in regenerative medicine 
 
Stem cells are an undifferentiated cell type and are able to divide 
continuously and produce cells that are committed towards a lineage of 
mature cells that become functionally integrated into an organism. These 
two hallmarks of stem cells are called self-renewal and differentiation 
capacity. 
Stem cells are classified according to their potential to give rise to a 
larger or smaller variety of committed cells. Totipotent stem cells are able to 
give rise to a new individual if provided with appropriate maternal support. 
Thus only the zygote and its immediate progeny up to the blastula stage are 
totipotent cells, because each individual cell can newly generate all 
embryonic and extra-embryonic tissues required for mammalian 
development (17). These cells are termed embryonic stem cells (ES cells). 
The cells of the Inner Cell Mass (ICM) are pluripotent because they can give 
rise to all cell types of the organism. However, in contrast to totipotent cells 
they can only reintegrate into a developing organism, they are not able to 
form a whole organism alone. Stem cells that are committed to differentiate 
into all cell types of one germ layer have been termed multipotent stem cells, 
such as neural stem cells. Unipotent cells are restricted to giving rise to only 
one cell lineage and cell type, such as B-lymphocytes. 
Because of their developmentally inhabited potential, stem cells hold 
a large therapeutic promise. The underlying reasons in many diseases are 
the malfunction or death of a more or less specific cell type or confined 
area(s) within the organism. An ideal treatment would therefore be to 
substitute diseased cells with the healthy counterpart.  
This has long been successful for Leukemia, which is a cancer of 
leukocytes (white blood cells). Like other blood cells, leukocytes are made in 
the bone marrow through a process that begins with multipotent adult stem 
cells. Leukemia is the result when leukocytes begin to grow and function 
abnormally, impeding immunological functions and functions of other 
organs. Routine treatment for leukemia is chemotherapy, which uses potent 
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drugs to target and kill the abnormal cells. Stem cell transplants from bone 
marrow, peripheral blood or umbilical cord blood stem cells are then used to 
rebuild the bone marrow.  
There are a number of neurodegenerative diseases where stem cells 
could prove a good treatment but have not been successfully employed: 
Stroke causes an irreversible, locally restricted loss of neuronal 
circuitry and supporting glial cells with consecutive functional deficits and 
disabilities. Preclinical and clinical cell-based studies focus on stem cells 
derived from the adult central nervous and hematopoietic systems. An 
increasing number of studies provide evidence that hematopoietic stem 
cells, either after stimulation of endogenous stem cell pools or after 
exogenous hematopoietic stem cell application, improve functional outcome 
after ischemic lesions (reviewed by (57,187)).  
Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating 
disease that affects the central nervous system (CNS). In a mouse model of 
MS, experimental autoimmune encephalomyelitis (EAE), injection of neural 
stem cells into the tail vein resulted in an increase in glial cells (135).  
Amyotrophic lateral sclerosis (ALS) is a progressive disease that 
manifests as a gradual evolution, spread of weakness and wasting of the 
affected patient's muscles. The direct underlying cause is the progressive 
loss of the muscles' motor neurons. Stem cells would have to replace 
motoneurons and integrate into every segment. Additionally, they needed to 
make a meter long branch to integrate functionally. Alternatively, the stem 
cells could be induced to differentiate into supporting cells, glia, or 
interneurons that might produce factors that would support motor neurons, 
or perhaps the stem cells themselves might produce such factors (reviewed 
by (171)). Transplantation studies in a mouse model resulted in a significant 
increase of the average life span of transgenic mice by 10–20% as well as 
motor function improvement (38,49). Habisch and colleagues however 
demonstrated that the cell number might be crucial for a beneficial outcome 
of a transplantation procedure (58).  
Alzheimer's disease (AD) is a neurodegenerative disease that 
includes progressive cognitive deterioration together with a declining ability 
to perform activities of daily living, neuropsychiatric symptoms or behavioral 
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changes. Plaques which contain misfolded peptides called amyloid beta (Aβ) 
are formed in the brain many years before the clinical signs of Alzheimer's 
are detected. Immortalized neuroepithelial stem cells injected into various 
brain regions of 2-years-old rats displayed incorporation and migration in the 
host brain with substantially reversed cognitive declination associated with 
aging, suggesting a potential for neuroreplacement strategies also for age-
associated neurodegenerative diseases (67). However, the ubiquitous 
decline of neurons makes it hard to restore all functions by cell replacement 
strategies. 
Parkinson's disease (PD) is characterized by muscle stiffness of limbs 
and trunk (rigidity), trembling in hands, arms, legs, and face (tremor), 
impaired balance and coordination (postural instability) and a slowing 
(bradykinesia) or loss (akinesia) of physical movement. Typical non-motor 
symptoms include disorders of mood, behavior, thinking, and sensation. The 
primary symptoms result from a decreased stimulation of the motor cortex 
by the basal ganglia, caused by the insufficient formation and action of 
dopamine. Dopamine is produced by dopaminergic neurons in the 
substantia nigra pars compacta that project to the striatum. Their loss in 
Parkinson’s disease leads to alterations in the activity of the neural circuits 
within the basal ganglia that regulate movement.  
At present, there is no cure for PD, but medications or surgery can 
provide relief from the symptoms. L-DOPA (Levodopa), which is considered 
the gold standard as treatment, is metabolized to dopamine in dopaminergic 
neurons and compensates the loss of dopamine. Because only 1-5% of L-
DOPA reaches the dopaminergic neurons and the rest of the drug is 
metabolized elsewhere, side-effects occur than can be treated with 
Carbidopa which prevents premature metabolization of Levodopa. 
Dopamine agonists and deep brain stimulation are mainly used when 
Levodopa therapy causes problems or is no longer effective.  
Parkinson’s disease is an ideal neurodegenerative disease for 
transplantation strategies, because studies can focus on a very distinct cell 
type that dies and cell replacement can focus on a particular area. 
Additionally, transplanted cells do not need to functionally integrate into the 
neuronal network of the host; as long as they release dopamine they will 
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treat the disease symptoms. Many kinds of cells have been considered for 
cell replacement therapies in Parkinson’s disease (reviewed by (64,171)). 
Primary cells have been successfully transplanted to diseased brains 
(44,86,99,125) but they impose ethical as well as logistical problems 
because they are taken from aborted fetuses and 8-9 fetuses are needed to 
isolate a cell number that will treat one patient (98,99). 
Stem cells promise to overcome this shortage (reviewed by 
(47,62,70,116,162)). ES cells have the largest potential because they self-
renew indefinitely and generate virtually all cell types of an organism. 
However, until now it has been impossible to suppress the potential of ES 
cells for uncontrolled growth leading to tumors in transplanted hosts 
(16,19,33,100). Neural stem cells (NSCs) are able to differentiate into the 
major cell types of the nervous system and have been shown to integrate 
and improve motor function in mouse models of PD (18,24,43,179). They 
are not prone to uncontrolled cell proliferation in the host, but the yield of 
expansion which is crucial for cell numbers for transplantation is lower than 
with ES cells.  
In summary, the ideal cell source for transplantation strategies would 
be stem cells that are expanding fast and virtually forever, retaining their 
differentiation capacity and inhabiting no risk to form tumors. Their 
production would be possible to standardize. Neural stem/progenitor cells 
(NPCs) from fetal tissue are a rapidly dividing source of cells that are able to 
generate cells of all three neural lineages and do not divide uncontrolled 
once transplanted into a host organism. Thus, at present, they are the ideal 
cell source for cell replacement strategies. 
 
1.2 Neural stem/progenitor cells 
 
Stem cells that are multipotent and have the potential to generate all 
cells from the nervous tissue are tissue-specific neural stem cells. Because 
they divide for a long time in vitro, yet probably not unlimited, they are 
usually referred to as neural progenitor cells (NPCs)(12).  
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They were first detected in 1965 by Altman et al. (3,4) but were then 
long forgotten until the 1990s when their existence was confirmed by several 
researchers in multiple brain areas in the adult and fetal brain 
(2,23,39,53,103,175). Accordingly, clonogenic NPCs can be directly isolated 
from fetal or adult nervous tissue, or derived from ES cells (29,47,78, 
101,116,168,178) (Fig. 1).  
NPCs have been categorized as multipotent stem cells derived from 
the nervous system with the capacity to regenerate and to give rise to cells 
belonging to all three major cell lineages of the nervous system, namely 
neurons, oligodendrocytes and astrocytes (1,8,29,47,78,101,116,136, 
168,178). 
In vivo, fetal neural stem cells form from neuroectodermal tissue 
when neurogenesis starts. The unilayered neuroepithelial tissue transforms 
into tissue with multiple cell layers between embryonic day (E) 10 and E12 in 
most areas of the mouse brain (59,123). Neuroepithelial cells give rise to 
radial glial cells that appear to be more fate-restricted and successively 
replace neuroepithelial cells. In contrast to neuroepithelial cells, radial glial 
cells show astroglial markers, such as GLAST (astrocyte-specific glutamate 
transporter), S100β, Gfap (glial fibrillary acidic protein), vimentin and BLBP 
(brain-lipid-binding protein)(59,110,123). Otherwise both stem/progenitor cell 
types are related. It has been proposed that they first divide symmetrically to 
increase the pool of stem cells, but later divide asymmetrically, generating a 
stem cell that remains in the ventricular zone and a daughter cell that 
becomes either a more restricted (intermediate) progenitor or terminally 
differentiates and migrates radially outward (52,60). The accumulation of 
daughter cells thickens the developing brain and radially stretches 
neuroepithelial cells. This division in the subventricular zone amplifies the 
number of cells produced by a given NPC division and may be an important 
determinant of brain size, since species with larger brains have a larger pool 
of intermediate progenitors (112). 
In vitro, most studies regarding fetal midbrain tissue involved rodent 
embryos at embryonic day (E)14 to E15 (101,136,158,159), while on human 
midbrain material, samples of 6-9 weeks post-fertilization (88,160) were 
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Fig. 1 The origin of NPCs and in vitro derivatives. Different populations of NPCs 
appear during embryo development and in the adult brain (center of scheme). During neural 
plate induction and soon after neural tube closure, the majority of cells are neuroepithelial 
NPCs. As neural tube development proceeds, radial glial cells appear and become an 
important NPC population. Eventually, radial glial cells could generate the putative 
astrocyte-like NSC present in the adult subventricular zone. Different culture techniques 
allow in vitro expansion of NPCs (left of scheme). Multipotent FGF2-responsive NPCs can 
be expanded in vitro under adherent conditions from neural tubes at very early 
developmental stages. Embryo FGF2-responsive NPCs generate in vitro the Fgf-2/Egf-
responsive, neurosphere-forming NPCs. Radial glial cells and probably other precursors 
naturally become Fgf-2/Egf-responsive, neurosphereforming NPCs during neural tube 
development. The lineage relationship between embryo and adult NPCs and these 
relationships with their in vitro derivatives remains uncertain (“?” in the scheme). Finally, 
NPCs can be completely generated in vitro from ES cells, pluripotent stem cells derived 
from the blastocyst inner cell mass (top of the scheme). ES cells differentiate into NPCs in 
vitro through formation of embryoid bodies or as adherent monolayers from dissociated 
cells. According to Baizabal et al. (12).  
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used (reviewed by (161)). After isolation, NPCs were plated in low-
attachment culture flasks in serum-free media containing serum 
supplements, such as N2 or B27 (144,159,160,178). Gensburger and co-
workers described fibroblast growth factor-2 (FGF-2; formerly basic 
fibroblast growth factor) inducing proliferation of neural precursors in 
embryonic hippocampal cultures (50). Later epidermal growth factor (Egf) 
was found to stimulate the growth of striatal precursors retaining their ability 
to differentiate into all major types of CNS cell types (140). Since these early 
studies most protocols for in vitro proliferation of both fetal and adult NPCs 
use the mitogens Fgf-2 and Egf alone or in combination in serum-free-media 
((158), for review see Svendsen et al. (168)). Various other epigenetic 
approaches have been employed for enhanced in vitro cultivation of NPCs 
including erythropoietin (156) and ATP (97). For some of these proliferating 
factors it is not completely clear how these factors influence the 
differentiation potential into neurons and glial cells (185). 
Another established neuroproliferative substance is leukemia 
inhibitory factor (LIF): When added to the culture medium, LIF allows 
continuous cell growth in human NPC cultures (25). LIF acts through the 
gp130 signal transducing subunit and is also required for the continuous 
growth of mouse, but not human ES cells. LIF appears to maintain these 
cultures in a proliferative state by preventing differentiation. Another strategy 
to enhance proliferation and to increase culture time is genetic manipulation 
by transduction of immortalizing genes into neural progenitors (for review, 
see (113,185)).  
Fetal stem or progenitor cells grow in cellular aggregates called 
“neurospheres”, but alternatively they can be expanded as adherent cell 
cultures on poly-L-ornithin/fibronectin-coated surfaces with both Egf and Fgf-
2 as mitogens.  
Crucial for many types of neural stem (progenitor) cell cultures seems 
to be reduced atmospheric oxygen (159,160,163). For example, in contrast 
to precursor cells derived from human forebrain samples, which are easily 
expanded by using Egf/Fgf-2 in 21% O2, precursors derived from the human 
mesencephalon do not show any proliferation under these conditions or do 
not differentiate into dopaminergic neurons in vitro (160,169,170). Under 
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these conditions, Egf/Fgf-2-responding NPCs with dopaminergic potential 
from rat and human midbrain tissue of less than 20 weeks post fertilization 
can be successfully expanded for over 1 year. However, the way in which 
these proliferation factors influence the differentiation of NSCs into distinct 
subsets of neurons or glial cells is currently not completely clear (185). 
Smith et al. showed that there are fundamental differences between NPCs 
of different species. In their study, rat NPCs proliferated more rapidly than 
mouse NPCs, but the authors also stressed that they used recombinant 
human growth factors which might have a higher affinity to rat receptors 
(158). Fetal rodent (122,166,167) as well as human (45,169) NPCs have 
been successfully transplanted into animal models of Parkinson’s disease 
and survive, differentiate and migrate in the host brain, providing proof of 
principle for stem cell transplantations. However, optimal conditions resulting 
in better symptomatic relief or recovery have not been specified to date. 
Adult neural stem cells reside in the subventricular zone of the lateral 
ventricles and the subgranular zone of the hippocampus. Studies 
demonstrated the isolation and in vitro expansion of neural progenitor cells 
(NPCs) from different regions of the adult rodent brain including cortex, 
amygdala, hippocampus and SVZ (3,4,8,14,72,88,93,104,106,118,119, 
124,146,184); reviewed by (48,127,174), but there are only a few reports 
about adult human NPCs in vitro (63,72,88,108,146). Adult NPCs have been 
transplanted with varying outcome (30,120,143). 
Derivation from ES cells yields neural stem cells with a large potential 
(69,173) that can subsequently be efficiently differentiated into neurons 
(75,76,91). However, their proliferative potential seems to be responsible for 
the high risk of tumor formation after transplantation (5,16). In addition, there 
are immense ethical concerns regarding the use of human ES cells and 
government restrictions that will, at least for the forthcoming years, render it 
unlikely that these cells will be therapeutically employed in many countries. 
Furthermore, there is evidence for multipotent adult stem cells from 
other tissues that seem to have the potential to transdifferentiate into 
neuroectodermal lineages (71,148,176). In contrast to ES cells, multipotent 
stem cells are often defined by the organ from which they are derived. 
Multipotent adult stem cells are of special interest with regard to autologous 
 
20 
transplantation approaches because immunological rejection could be 
circumvented. An important source of multipotent adult stem cells is bone 
marrow stromal cells (MSCs); also known as mesodermal stromal cells or 
mesenchymal stem cells. In contrast to human ES cells or human brain-
derived NPCs, human MSCs (hMSCs) are easily isolated and can be 
expanded over a long period of time without serious ethical and technical 
problems. MSCs can be cultivated in vitro and contain progenitors capable 
of generating osteocytes, chondrocytes and adipocytes (46,139,153). 
Several reports demonstrate that under specific experimental conditions 
MSCs can also differentiate into cells that are not part of their normal 
repertoire: skeletal and cardiac muscle, hepatocytes, and glia 
(11,41,61,109,126,148,149). Functional neurons however have been 
conclusively demonstrated only in mouse and genetically modified human 
MSCs. 
Various molecular markers identifying NPCs and their sequential 
differentiation stages are known to date (48). The first marker defining NPCs 
was the intermediate filament protein nestin (92), but some neural precursor 
cells are nestin-negative (89) and, on the other hand, nestin is expressed by 
other cell types, including non-neural cells (154). Other stem cell markers 
include Musashi1 and 2, Prominin-1 (cd-133), Notch1, Sox-1, and Sox-2 
(36,42,47,74,85,90,150,177,182). However, it is necessary to point out that 
these markers are arbitrary and their significance depends in part on the 
state and microenvironment in which the cells are located or isolated from. 
Thus, NPCs are usually identified operationally by their biological 
behavior after isolation: They grow in floating, multicellular aggregates, so-
called ‘neurospheres’ (47,116) and are able to self-renew and differentiate 
into the three major cell types of the nervous tissue. Uchida and colleagues 
performed an extensive analysis of surface markers on neurospheres from 
human origin. They defined a subset of human NPCs as phenotypically 
CD133-positive, but negative for the hematopoietic stem cell marker CD34 
and negative for CD45 (177). Recently the expression of various proneural 
genes like SOX1, Musashi1, Otx-1, Otx-2, NeuroD1 and Neurogenin-2 was 
reported in mammalian NPCs, showing their neuroectodermal origin (9,22). 
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NPCs have been isolated from different species and origins with 
different characteristics and potentials but so far no source produced stem 
cell cultures that behaved optimal in transplantation studies in terms of graft 
survival, differentiation and tumor growth. Therefore, the characteristics of 
NPCs and their manipulation need to be investigated more detailed. 
 
1.3 Generation of dopaminergic neurons 
 
In vivo mesencephalic dopamine (mDA) neurons are generated in the 
ventral midbrain at three different positions (substantia nigra (A9), ventral 
tegmental area (A10) and the retrorubral field (A8)) during a restricted time 
period starting at embryonic day (E) 10.5 in the mouse (13). This is 
accomplished by a complex interplay of different instructive signals from 
several important signaling centers in the brain. Along the dorsoventral axis, 
the ventral (floor plate) and the dorsal (roof plate) midline are responsible for 
the secretion of signaling molecules, like the lipid-modified glycoprotein 
Sonic hedgehog (Shh) from the ventral midbrain floorplate. Midbrain 
patterning along the anterior-posterior axis is achieved mainly by the 
midbrain-hindbrain boundary (MHB), at or across which Wnt1, Fgf-8, Pax2/5 
and Engrailed (En) 1 and 2 are secreted. It was shown that Shh and Fgf-8 
together were necessary (and sufficient) to generate ectopic mDA neurons 
in rat embryo cultures (186). Work with knockout mice and mouse embryo 
explant cultures described that additionally Wnt1 is needed for the induction 
of mDA neurons (137). Downstream of Shh, Fgf-8 and Wnt1, Lmx1b, Lmx1a 
and further Pitx3 and Nr4a2 (Nurr1) are required for the normal generation 
of dopaminergic neurons (6,137,147,157). 
In vitro adult stem (progenitor) cells (aNPCs) from different 
neurogenic and non-neurogenic regions have the potential to give rise to 
cells belonging to all three major cell lineages of the nervous system; 
neurons, oligodendrocytes, and astrocytes in vitro (95,129,131,155). 
Hermann and colleagues differentiated NPCs from the mouse midbrain and 
investigated their dopaminergic differentiation potential. They established 
the isolation, expansion and in vitro characterization of adult mouse midbrain 
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NSCs and their differentiation into functional nerve cells including 
dopaminergic neurons (65).  
Fetal NPCs have also been shown to generate oligodendrocytes, 
neurons, and astrocytes in vitro (1,8,29,78,101,136,168,178) in a ratio of 
approximately 1:5:25 (56,73) after the removal of growth factors in serum-
free media on standard culture growth surfaces, such as poly-L-lysine or 
laminin (55).  
In the CNS, patterning in the anterior-posterior and dorsal-ventral 
axes occurs early, concomitantly with neural induction. Indeed, 
neurospheres generated from different CNS regions express region-
appropriate markers and generate region-appropriate progeny. Spinal cord 
stem cells generate spinal cord progeny (115), whereas stem cells from the 
forebrain generate more gamma-aminobutyric-acid- (GABA-) containing 
neurons than dorsal stem cells (136). Consistently, only NPCs isolated from 
the midbrain differentiate into functional mature dopaminergic neurons 
(101,136,150,160). Consequently, it has been postulated that stem cells and 
restricted precursors exhibit regionalization (66,79,128,158) but may not be 
committed to that fate (66). Additionally, Smith et al. showed that the 
potential of rat NPCs to generate neurons rapidly disappears in vitro under 
the culture conditions used (Egf,Fgf-2, atmospheric oxygen levels (158)). 
This differentiation programme can be influenced in vitro by addition 
of growth factors or cytokines. Since NPCs have been suggested as a new 
source of tissue for regenerative therapy in PD (15,35), several studies on 
midbrain-derived NPCs have focused on the induction of a dopaminergic 
phenotype. During the last few years many aspects of the genetic and 
epigenetic control of the induction and phenotypic maturation of 
dopaminergic neurons have been characterized (for review see (133). 
Instructive signals for the generation of progenitors capable of differentiation 
into dopaminergic neurons are Fgf-8, Shh and Wnt1 (Fig. 2). Midbrain 
derived precursors apparently do not require those signals (178) but need 
activation of signaling cascades leading to the expression of two crucially 
involved transcription factors: Nr4a2 and Pitx3 (Fig. 2). 
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Fig. 2 Downstream of the inductive signals Fgf8, Shh and Wnt1, expression of transcription factor 
genes and mdDA-specific genes is acquired at different stages of differentiation: initially, the 
expression of the Otx1, Nkx2.2 and Sox2 genes, followed by Lmx1a, Msx1, Ngn2, Otx2 and Foxa2 
transcription factors. As part of the transcriptional code, several of these are repressed during further 
development (e.g. Sox2, Nkx2.2 and Nkx6.2). The early stage of mdDA-specific differentiation (at E9–
E10 in mice) further involves Lmx1b, the engrailed factors En1 and En2, and Foxa1. At this stage, the 
first gene for dopamine synthesis, amino acid decarboxylase (Aadc), is induced. Subsequently, 
transcription factors for terminal differentiation are induced: Nr4a2 (Nurr1) at E10.5 and Pitx3 at E11.5. 
Pitx3 is required for survival of some terminally differentiating subsets of mdDA neurons. Ilf1 is a 
newly discovered forkhead factor, expressed at E12.5. Nurr2 is required for induction of tyrosine 
hydroxylase (Th) at E11.5, of vesicular monoamine transporter 2 (Vmat2) at E12.5, and of the 
dopamine transporter (Dat) at E14, at which point the cells are mature mdDA neurons of the 
substantia nigra (SN) or ventral tegmental area (VTA). Aldehyde dehydrogenase A1 (Aldh1a1) is 
expressed in proliferating mdDA progenitors. In this figure, expression of transcription factors is linked 
to stages of mdDA development as marked by components of dopaminergic-neuron synthesis and 
transmission, but no functional genetic relationship is inferred. According to Burbach and Smidt (20). 
 
 
For example, Nr4a2 was reported to be upregulated by the 
differentiation factor interleukin-1 (IL-1) in mesencephalic precursor cells 
from rat (26). Also, the overexpression of Nr4a2 induced a midbrain 
dopaminergic phenotype after the stimulation of NPCs with astrocyte-
conditioned medium (81,82,183). Consistently, Ling and co-workers 
demonstrated with rat-derived neural progenitor cells that IL-1 was able to 
induce the dopaminergic phenotype with a significantly increased effect by 
adding other factors, such as IL-11, LIF, glial-derived neurotrophic factor 
(GDNF) and membrane fragments in midbrain NPCs, but not in striatal 
NPCs (101). These dopaminergic cells show all the major morphological 
features and functional properties of mature dopaminergic cells, such as 
dopamine production/release and the expression of sodium and 
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hyperpolarization induced cation channels (159). IL-1 was potent in inducing 
the dopaminergic phenotype not only in rat but also in human NPCs 
(26,74,101,160). Transforming growth factor β was used to increase 
dopaminergic cell numbers in short-term fetal mouse NPC culture (10d), 
whereas double knockout mice (Tgf-β2 -/-/Tgf- β3 -/-) displayed significantly 
less Th+ cells in the midbrain than wt mice, showing that Tgf β is a beneficial 
or necessary factor for dopaminergic neurons (145). Wnt5a overexpression 
and recombinant protein was used to obtain more TH+ cells in rat NPCs 
(27,28,132). Transplantation of Wnt5a overexpressing cells resulted in 
significant cellular and functional recovery in parkinsonian mice. When 
Nr4a2 and Ngn2 were overexpressed in ventral mesencephalic NPCs from 
E11.5 mice, dopaminergic neurons with mature phenotypes were induced 
(7,183). Other ways have not been successful in generating dopaminergic 
neurons from long-term expanded fetal mouse NPCs (31,83). Long-term 
expansion however is essential to stem cell research, because it is 
necessary to obtain large quantities of cells for future cell replacement 
strategies and to eliminate primary cells carried over from the isolation 
process. 
All reports using fetal mouse NPCs for the establishment of 
substances promoting dopaminergic or neuronal differentiation have used 
short-term expanded cultures, making it difficult to ensure that real 
differentiation instead of dopaminergic neuron survival took place 
(28,40,132,145,150). In contrast, several reports demonstrated long-term 
expansion and subsequent dopaminergic differentiation of human and rat 
fetal NPCs (26,27,84,100,117,159,160,168).  
Transplantation of expanded and in vitro differentiated neural 
precursors resulted in a survival rate of 3-5% of the cells and behavioral 
recovery of parkinsonian rats with no indication of uncontrolled growth of the 
transplanted cells (164) making NPCs from fetal tissue to date the only 
suitable cell source for transplantation strategies in neurodegenerative 
diseases because they do not form tumors and have the potential to 
generate functional dopaminergic neurons. 
Additionally, Parkinson’s disease is the ideal neurodegenerative 
disease for transplantation strategies because of a confined cell loss. To 
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approach the goal of cell replacement the precise regimens governing the 
differentiation of fetal NPCs into dopaminergic neurons need to be 
elucidated.  
 
1.4 Aims of the thesis 
 
Fetal mouse NPCs are a crucial tool for investigations on neural stem 
cell differentiation, because they make the employment of transgenic 
animals in vivo and cells in vitro possible. So far only short-term expanded 
NPC cultures displayed dopaminergic neurons and it is not clear whether 
this was due to differentiation or a result of increased survival of primary 
dopaminergic neurons. 
The aims of the thesis were to characterize mouse fetal NPCs, to 
establish the long-term expansion of fetal mouse NPCs and the generation 
of dopaminergic neurons in long-term expanded fetal mouse NPCs, to 
investigate the signaling mechanisms involved in the differentiation of mouse 
fetal NPCs towards the dopaminergic phenotype and to compare NPCs that 
were cultivated for short periods in vitro with long-term expanded NPCs. 
 To this end fetal NPCs had to be isolated and long-term expanded. 
This was necessary to obtain large quantities of cells and to overcome 
contaminations of primary cells from the isolation process. The proliferation 
as well as differentiation potential of NPCs from different developmental 
origins (E10, E12 and E14) was described. Their ability to develop neural 
cells of all three lineages as well as neuronal subtypes was determined. The 
activation of p38 and Erk1/2 signaling cascades in response to the initiation 
of dopaminergic differentiation by potent inducers of the dopaminergic 
phenotype was analyzed. The expression of signaling molecules potentially 
involved in the dopaminergic specification was investigated. Additionally, 
short-term expanded NPCs were analyzed for their proliferation and 
differentiation potential. They were FACS-sorted to prove the in vitro 
differentiation from precursor cells. Finally, short-term and long-term NPC 
cultures were compared on the mRNA level to find markers describing stem 
cells in vitro.  
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The results to these experiments should help answer the following 
questions: Can dopaminergic neurons be generated de novo from fetal 
mouse NPCs in vitro? Which signaling pathways/molecules are involved in 
the dopaminergic specification of fetal mouse NPCs? Do short-term and 
long-term NPCs differ from each other? 
The results of this project will have an impact on neural stem cell 
science because no real differentiation of fetal mouse NPCs has been 
demonstrated to date. 
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2. Material 
 
2.1. Instruments 
 
 
Instrument Designation Company 
 
Balance SBA 52  Scaltec (Göttingen, Germany) 
Cell incubator Hera Cell 150  Heidolph (Düsseldorf, Germany) 
Cell Prep Instruments various  VWR (Darmstadt, Germany) 
Centrifuge, big 5810 R  Eppendorf (Hamburg, Germany) 
Centrifuge, small Mini Spin Plus  Eppendorf (Hamburg, Germany) 
Clean bench Hera Safe  Heraeus (Berlin, Germany) 
Confocal Microscope DMIRE2  Leica (Braunschweig, Germany) 
Cryostat 2800 FrigoCut E Reichert-Jung (Nussloch,  
                                  Germany) 
FACS Sorter FACSCalibur  BD Biosciences (Franklin, USA) 
Fluorescence microscope DM IRE2  Leica (Braunschweig, Germany) 
Magnetic stirrer RCT basic  IKA Labortechnik (Staufen, 
                                      Germany) 
Orbital shaker Polymax 1040  Heidolph (Düsseldorf, Germany) 
Perfusion Pump Dynamax  Rainin (Oakland, USA) 
PCR cycler MX 3000 P  Stratagene (La Jolla, USA) 
Photometer Bio Photometer  Eppendorf (Hamburg, Germany) 
Plate reader Sunrise  Tecan (Crailsheim, Germany) 
Rotator OV 3  Biometra (Göttingen, Germany) 
Thermocycler                Thermomixer Comfort  Eppendorf (Hamburg, Germany) 
Vortexer L 46  GLW (Würzburg, Germany) 
Water bath SW 22  Julabo (Seelbach, Germany) 
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2.2. Chemicals and Consumables 
 
 
Substance or Consumable  Company 
 
Agarose Biozym LE (H. Oldendorf, Germany) 
BrdU (5’Bromo-2’-Desoxyuridine) Serva (Heidelberg, Germany) 
Cell culture filter Millipore (Billerica, USA) 
Eight-well chambers BD Biosciences (Franklin, USA) 
Fibronectin Sigma-Aldrich (St. Louis, USA) 
Glucose Sigma-Aldrich (St. Louis, USA) 
Microscope slides Langenbrinck (Teningen, Germany) 
Microscope cover slips Marienfeld (Germany) 
Non-adhesive culture flasks  Greiner bio-one (Frickenhausen, 
              Germany) 
Paraformaldehyde (PFA) Sigma-Aldrich (St. Louis, USA) 
Poly-D-Lysine Sigma-Aldrich (St. Louis, USA) 
Poly-L-Ornithine Sigma-Aldrich (St. Louis, USA) 
Sucrose VWR (Darmstadt, Germany) 
Tris Roth (Karlsruhe, Germany) 
Triton-X 100 Serva (Heidelberg, Germany) 
Trypsin (cell-culture) Gibco (Invitrogen; Carlsbad, USA) 
Trypsin (cell prep) Sigma-Aldrich (St. Louis, USA) 
 
General consumables and chemicals were purchased from Sigma, Roth, 
Merck, Greiner or Eppendorf. 
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2.3. Solutions, Buffers 
 
Substance or Consumable  Company 
 
5x Taq M Enhancer    Eppendorf (Hamburg, Germany) 
10x Taq Buffer    Eppendorf (Hamburg, Germany) 
Taq Polymerase    Eppendorf (Hamburg, Germany) 
Accustain    Sigma-Aldrich (St. Louis, USA) 
dNTP’s (2mM)    Eppendorf (Hamburg, Germany) 
Donkey serum    Jackson Immunoresearch (USA) 
HBSS    Gibco (Invitrogen, Carlsbad, USA) 
Hoechst 33342    Molecular Probes (Eugene, USA) 
PBS    Gibco (Invitrogen, Carlsbad, USA) 
Tissue Tek O.C.T. Compound    Jung (Nussloch, Germany) 
Vectashield    Vector (Burlingame, USA) 
Ultra Pure (PCR-) Water    Roth (Karlsruhe, Germany) 
 
 
2.4. Kits 
 
 
Kit  Company 
 
Brilliant® SYBR® Green QRT-PCR Master Mix Stratagene (La Jolla, USA) 
RNeasy® Mini Qiagen (Hilden, Germany) 
DNeasy Blood and Tissue Qiagen (Hilden, Germany)
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2.5. Enzymes, Growth factors and Antibodies 
 
2.5.1. Enzymes 
 
Enzyme  Company 
 
DNase (for Cell Prep) Sigma-Aldrich (St. Louis, USA) 
DNase (for RNA isolation) Qiagen (Hilden, Germany) 
Trypsin Sigma-Aldrich (St. Louis, USA) 
 
2.5.2. Growth factors 
 
Growth factor  Company 
 
Egf (human, recombinant) Invitrogen (Carlsbad, USA) 
Fgf-2 (bFGF) (human, recombinant) Sigma-Aldrich (St. Louis, USA) 
IL-1 (Interleukin-1) (human, recombinant) Sigma-Aldrich (St. Louis, USA) 
Forskolin (human, recombinant) Sigma-Aldrich (St. Louis, USA) 
Fgf-8 (human, recombinant) R&D Systems (Minneapolis, 
USA) 
Shh (human, recombinant) R&D Systems (Minneapolis, 
USA) 
 
 
2.5.3. Primary Antibodies 
 
Antibody  Company 
  
Mouse anti-Nestin (1:500)  Chemicon (Billerica, USA) 
 
Mouse anti-Galactocerebrosidase Chemicon (Billerica, USA) 
                  (GalC; 1:750) 
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Mouse anti-Microtubuli-associated  BD Biosciences (Franklin, USA) 
                   Protein (Map2ab) 2ab(1:500) 
 
Rabbit anti-ß-III-Tubulin (1:2000) Covance (Princeton, USA) 
 
Rabbit anti-tyrosine hydroxylase PelFreeze (Rogers, USA) 
                                      (Th; 1:200) 
 
Rabbit anti-Nestin (1:500) Abcam (Cambridge, UK) 
 
Rabbit anti-Ki-67 (1:500) Novocastra (Newcastle, UK) 
 
Rabbit anti GABA (1:1000) Sigma (St. Louis, USA) 
 
Rabbit anti Serotonin (1:1000) Sigma (St. Louis, USA) 
 
Rabbit anti Glutamate (1:2000) Sigma (St. Louis, USA) 
 
Rabbit anti Chat (1:1000) Chemicon (Billerica, USA) 
 
Rat anti-5’Bromo-2’ desoxyuridine Abcam (Cambridge, UK) 
                                      (BrdU;1:100) 
 
Chicken anti Glial Fibrillary Acetic Protein Abcam (Cambridge, UK) 
                                   (Gfap; 1:1000) 
 
 
 2.5.4. Secondary Antibodies 
 
Antibody  Company 
 
Alexa Fluor® 647 conjugated donkey  Invitrogen-Molecular Probes 
anti-goat antibody  (Carlsbad, USA) 
Alexa Fluor® 647 conjugated donkey  Invitrogen-Molecular Probes 
anti-mouse antibody  (Carlsbad, USA) 
Alexa Fluor® 488 conjugated donkey  Invitrogen-Molecular Probes  
anti-mouse antibody (Carlsbad, USA)  
Alexa Fluor® 555 conjugated donkey  Invitrogen-Molecular Probes 
anti-mouse antibody  (Carlsbad, USA)  
Alexa Fluor® 488 conjugated donkey  Invitrogen-Molecular Probes 
anti-rabbit antibody  (Carlsbad, USA)  
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Alexa Fluor® 594 conjugated donkey  Invitrogen-Molecular Probes 
anti-rabbit antibody  (Carlsbad, USA) 
Alexa Fluor® 647 conjugated donkey  Invitrogen-Molecular Probes 
anti-rabbit antibody  (Carlsbad, USA) 
Alexa Fluor® 555 conjugated donkey  Invitrogen-Molecular Probes 
anti-rat antibody  (Carlsbad, USA) 
Cy5 conjugated donkey anti chick antibody     Dianova (Hamburg, Germany) 
Cy3 conjugated donkey anti chick antibody     Dianova (Hamburg, Germany) 
FITC conjugated donkey anti chick antibody    Dianova (Hamburg, Germany) 
 
 
 
2.6. Oligonucleotides 
 
 
Name 5’-3’ sequence NBCI ACC # Product 
                                                                                                            length 
 
mm_HMBS_fwd TGTATGCTGTGGGTCAGGGAG NM_013551  144 bp 
mm_HMBS_rev CTCCTTCCAGGTGCCTCAGA  
  
mm_Aldh1a1_fwd TATGTTCTTGGAAATCCTCTGAC  NM_013467.3  110 bp 
mm_Aldh1a1_rev GCTCCTTCTTTCTTCCCACTC 
   
mm_Egf-R _fwd AGGGGACCAGACAACTGCAT NM_207655  119 bp 
mm_Egf-R _rev GCATCTGCATACTTCCAGACC  NM_007912 
 (2 transcript variants)  
 
mm_En1_fwd ACACAACCCTGCGATCCTAC NM_010133.1  138 bp 
mm_En1_rev GTGCGTGGACCAGAGGAC 
   
mm_En2_fwd GACTCGGACAGCTCTCAAGC NM_010134.3  109 bp 
mm_En2_rev ACCTGGGACCTGAAGAAGG 
   
mm_FoxA1_fwd CAGGAGGCCTACTCCTCTGTC NM_008259  102 bp 
mm_FoxA1_rev GCTCGTGGTCATGGTGTTC 
   
mm_FoxA2_fwd GCCAGCGAGTTAAAGTATGC NM_010446  110 bp 
mm_FoxA2_rev TCATGTTGCTCACGGAAGAG 
   
mm_GFAP_fwd GATCTATGAGGAGGAAGTTCG  NM_010277.3  183 bp 
mm_GFAP_rev TCTGCAAACTTAGACCGATACC 
    
mmGfp_fwd AAGTTCATCTGCACCACCG  n/a   ~450 bp 
mmGfp_rev TGCTCAGGTAGTGGTTGTCG 
  (amplifies genomic DNA)  
 
33 
 
mm_Lmx1a_fwd TGCAGAAAGGTGAGGGAGAC NM_033652  139 bp 
mm_Lmx1a_rev TGTTCTGTTGGTCCTGTTGC 
   
mm_Lmx1b_fwd GGCCAAGAGGTTCTGTCAAG n/a 
mm_Lmx1b_rev AAGGGGTCGCTACTTCCGTA 
 
mm_Map2ab_fwd AAAGTCACTGATGGAATAAGC NM_008632.2  172 bp 
mm_Map2ab_rev CCAGGTCAGAACCAATTCGCA 
   
mm_MBP_fwd CACGGGCATCCTTGACTC n/a 
mm_MBP_rev GCCGTGCTGCGACTTC 
 
mm_Msi_fwd GCAGACCACGCAGGAAG NM_008629.1  151 bp 
mm_Msi_rev CGCCAGCACTTTATCCAC 
   
mm_Msx1_fwd CAGCCAGACGGCTGAGTC NM_010835  124 bp 
mm_Msx1_rev TACTGCTTCTGGCGGAACTT 
   
mm_Nes_fwd TGGAACAGAGATTGGAAGGC  n/a 
mm_Nes_rev TCTTGAAGGTGTGCCAGTTGC  
 
mm_Ngn2_fwd CGGCGTCATCCTCCAAC  NM_009718.2  179 bp 
mm_Ngn2_rev  CGGGTAGAGGACGAGAGAGG 
   
mm_Nkx2.2_fwd GCCTCCAATACTCCCTGCAC  NM_010919  103 bp 
mm_Nkx2.2_rev  TTGTCATTGTCCGGTGACTC 
   
mm_Nurr1_fwd TGTCAGCACTACGGTGTTCG NM_013613.1  226 bp 
mm_nurr1_rev AGGGTAAACGACCTCTCCG 
   
mm_Otx1_fwd GTTCACAGCTGGACGTGCT NM_011023  118 bp 
mm_Otx1_rev AACCAGACCTGGACTCTGGA 
   
mm_Otx2_fwd GGTATGGACTTGCTGCATCC  NM_144841  112 bp 
mm_Otx2_rev GCTGTGCCCTAGTAAATGTCG 
   
mm_Pitx3_fwd GTGGACTCCTACAGATTGGC n/a 
mm_Pitx3_rev CGGATGTGACAGGATTCG 
 
mm_Prom_fwd ACCAACACCAAGAACAAGGC NM_008935.1  349 bp 
mm_Prom_rev GGAGCTGACTTGAATTGAGG 
   
mm_Sox-2_fwd GAACGCCTTCATGGTATGGT NM_011443  126 bp 
mm_Sox-2_rev TTCTCGGTCTCGGACAAAAG 
   
mm_Th_fwd GCCTTCCGTGTGTTTCAGTG  NM_009377.1  126 bp 
mm_Th_rev GGCAAATGTGCGGTCAGC 
   
mm_Tuj1_fwd TGAGGCCTCCTCTCACAAGT NM_023279  116 bp 
mm_Tuj1_rev TAAAGTTGTCGGGCCTGAAT 
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2.7. Cell Culture Media 
 
 
Expansion medium (EM) I (Serum-free) 
 
Medium component  Company 
 
32 % F-12 (Nutrient Mixture-Ham-) Gibco BRL (Tulsa, UK) 
65 % DMEM high Glucose Gibco BRL (Tulsa, UK) 
2 % B27 Gibco BRL (Tulsa, UK) 
1 % Penicillin/Streptomycin Gibco BRL (Tulsa, UK) 
20 ng/µl Egf Sigma (St. Louis, USA) 
20 ng/µl Fgf-2 Sigma (St. Louis, USA) 
 
2.8. Mice 
 
 
Male and female wild-type C57Bl6 (25-35 g) were purchased from 
Charles River, Sulzfeld, and TH-GFP/21-31 (Tg+) mice (114) were a gift 
from Dr. Kazuto Kobayashi. They were housed, bred and treated according 
to the guidelines of the European Community (86/609/EEC) and the Society 
for Neuroscience (January 1985). All experiments were approved by the 
local ethical committee. Timed pregnant females were obtained by overnight 
mating. The day of detection of the vaginal plug was considered as E1. 
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3. Methods 
3.1 Flowchart of Experiments 
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3.2. Cell biology 
 
3.2.1. Isolation of mesencephalic neural progenitor cells 
 
Fetal mesencephalic NPCs were isolated from brain tissue of E14, E12, and 
E10 mice embryos. Pregnant females were sacrificed according to NIH 
guidelines and the approval of the local animal care committee. The 
embryos were isolated and the embryonic midbrain was dissected. After 
removal of the meninges the tissue samples were cut into small pieces with 
a scalpel, incubated in 0.1% trypsin for 5 min, triturated and centrifuged for 3 
min at 500 x g. The supernatant was removed, 40 mg/ml DNase was added 
and the sample was homogenized to a quasi single cell suspension by 
gentle triturating using a fire polished Pasteur pipette. After centrifugation (3 
min, 500 x g) the supernatant was discarded and cells were re-suspended in 
pre-warmed expansion medium EM I containing 20 ng/µl Egf and Fgf-2. 8 ml 
of the culture were transferred to a 25 cm2 flask (about 2×106 viable cells per 
flask).  
All steps were performed at room temperature. 
 
3.2.2. Cultivation of suspension and adherent neural progenitor 
cells 
 
Cultures were incubated at 37°C, 5% CO2, 92% N2 and 3% O2 using an 
incubator equipped with an O2-sensitive electrode system. The medium was 
partly changed once or twice a week. For this, cells were transferred into a 
falcon tube and centrifuged (3 min, 500 x g) to remove the supernatant. After 
that, they were washed once by resuspension in about 5 ml PBS followed by 
another centrifugation step (3 min, 500 x g) before 4 ml old medium and 4 ml 
pre-warmed medium were added and the cells were transferred to a new 
culture flask again. Growth factors were added every other day. Fetal 
neurosphere formation was observed after 2-3 days. Neurospheres were 
 
37 
propagated up to 52 weeks, which corresponds to 52 passages. A new 
passage was generated simultaneously to the procedure for changing the 
medium, but the culture was distributed to several culture flasks thereby 
maintaining the initial amount of 2×106 viable cells per flask.  
Adherent NPCs were seeded at 1×106 viable cells per flask on previously 
Poly-L-Ornithine /Fibronectin coated dishes. In short, coating was done by 
incubating cell culture flasks with Poly-L-Ornithine solution (0.01%) overnight 
at 37°C with agitation. After rinsing three times with PBS Fibronectin solution 
(4µg/ml) was applied. After another incubation step for at least 3 h at 37°C 
and subsequent rinsing with PBS dishes were ready to use or stored at  
-20°C. Growth factors were added every other day. Cells were passaged 
once a week. Medium was removed and trypsin was added onto the cells. 
After a two minute incubation step at 37°C cells were rinsed off the dish and 
collected in a centrifuge tube. Cells were spun down and the supernatant 
was removed. Pre-warmed expansion medium EM I was added and 
subsequently the cell solution was seeded in new culture flasks to achieve a 
density of 1×106 viable cells per flask. 
 
3.2.3. Neurosphere forming assay 
 
To assess the ability of neural precursor cells to form neurospheres, a 
neurosphere forming assay was used. Freshly isolated neural precursor 
cells were counted using a Neubauer counting chamber. A dilution series 
was prepared from isolated neural precursor cells to obtain mathematically 
0.5, 1, 2, 4, 8, 15, 30, 61, 125, 250, 500, 1000 cells per well. The cell 
dilutions were seeded into a 96-well plate as octuplicates with Egf and Fgf-2 
and incubated at 37°C, 5% CO2, 92% N2 and 3% O2 for one week. Growth 
factors were added every other day.  
After one week, the number of negative wells was identified for each dilution. 
The fraction of negative wells for five individual experiments was quantified. 
A logarithmic trend line was used to describe the fraction of negative wells 
against the number of cells initially seeded per well. According to the formula 
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described by Levkovits and Waldmann (94) the number of cells needed to 
form one neurosphere was determined at 0.37 = fraction of negative wells 
(y).  
 
3.2.4. In vitro differentiation of neural precursor cells 
 
NPCs were differentiated by plating them onto poly-D-lysine-coated 
(50µg/ml) 24 well-plates or 6 well-plates at 50,000-150,000 cells per cm2 in 
standard medium without mitogens. In short, poly-D-lysine (aqueous 
solution) was pipetted into culture dishes and incubated for 1 h at 37°C or 
overnight at room temperature. After rinsing once with HBSS and four times 
with PBS the plates were immediately used for differentiation experiments. 
Neurosphere cultures in EM I medium were prepared and 500 to 2000 µl 
were filled into culture dishes according to their size. The following 
substances were used to induce differentiation: Interleukin (IL)-1 (100 
pg/ml), Fgf-8 (100 ng/ml), Shh (500 ng/ml) alone or in combination (Fgf-
8/Shh) and in combination with Forskolin (50 µM). The cells were allowed to 
differentiate for up to 14 days at 37˚C in a humidified atmosphere at lowered 
O2 conditions of 5% CO2, 92% N2 and 3±2% O2. Half of the medium was 
changed and cytokines/growth factors were supplemented every 3-4 days.  
 
3.2.5. Flow Cytometry 
 
Isolated fetal NPCs (E14) from pregnant Th-Gfp mice in a single cell 
suspension were filtered and subsequently processed by a FACSCalibur® 
FACS Sorter and analyses were performed with the Cellquest software (both 
from Becton Dickinson, Franklin Lakes NJ) in collaboration with the Max-
Planck-Institute for Cell Biology and Genetics. A Th-Gfp negative fraction 
and a mixed fraction were obtained and cultivated separately for one to two 
weeks and then subjected to differentiation. 
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3.2.6. Immunocytochemistry 
 
Immunocytochemistry allows localizing proteins within a cell by exploiting 
the principle of antibodies which bind specifically to the protein of interest. 
The primary antibody is then recognized by a secondary antibody linked to a 
fluorophore, thereby allowing specific visualization of the target protein. 
Cell culture plates were equiped with glass cover-slips before coating. Cells 
were cultivated on coated cover-slips according to the experimental design. 
At the end of the experiment the cells were washed once with PBS and 
subsequently fixed for 30 seconds using “Accustain” solution. After rinsing 
three times with PBS, parts of the surface not covered with cells were 
blocked against unspecific antibody labeling using blocking solution (3% 
donkey-serum in PBS containing 0.2% Triton) for 1.5 h. After that, primary 
antibodies were added and incubated overnight at 4°C. Subsequently, cells 
were rinsed three times with PBS and incubated with the corresponding 
fluorophore-labeled secondary antibodies (diluted 1:500 in PBS) for 1h at a 
dark place. After the incubation with the secondary antibodies, cells were 
rinsed three times with PBS and cell nuclei were counterstained with 
Hoechst 33342 staining solution (0.75 µl/ml) for 3 min. After rinsing again for 
three times with PBS, cover-slips were removed from the culture dish and 
transferred onto microscopy slides using mounting medium. Images were 
captured using a fluorescence microscope. 
Unless indicated differently, all incubation steps were performed at room 
temperature. 
 
3.3. Histology 
3.3.1. Perfusion 
 
Pregnant females at E14 post-fertilization were perfused to obtain 
E14 embryonic brain sections. Fix and wash bottle lines were cleared of any 
air bubbles. Wash solution was run through the canula to remove any fix 
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from lines and was then set at a slow drip. The anesthetized animal was 
placed on its back on a styropor block over a sink. Limbs were spread and 
each paw secured to the block.  
A cut along the sternum ~8 cm long was made; scissors were used to 
cut the diaphragm laterally on both sides and toward the head across ribs 
and parallel to lungs. The descending aorta was clamped. With a mosquito 
hemostat, one lung was reflected to locate the descending aorta as it runs 
along the spinal column. The aorta was clamped. A small pair of rat tooth 
forceps was used to grasp the ventral tip of the heart. The left ventricle was 
pierced with a scalpel, allowing the blade to penetrate far enough to make 
the slit large enough for the canula tip. The blade was quickly removed to 
prevent spurts from the long incision. The canula was inserted and directed 
up through the left ventricle into the ascending aorta. The aorta was 
clamped, holding the tip of the canula in place. After a brief wash step the fix 
line clamp and perfusion tube clamp were fully opened. The right auricle was 
punctured, allowing the escape of return circulation.  
After perfusion, embryos were dissected, post-fixed overnight, 
incubated in growing concentrations of sucrose solution and finally quick-
frozen and stored at -80°C. 
 
 
3.3.2. Immunohistochemistry 
 
Immunohistochemistry allows localizing proteins within a tissue by 
exploiting the principle of antibodies which bind specifically to the protein of 
interest. Such a primary antibody is then recognized by a secondary 
antibody linked to a fluorophore, thereby allowing specific visualization of the 
target protein. 
Whole embryos or embryonic brains were embedded in Tissue Tek 
O.C.T. Compound, and 20-30 µm thick sections were applied onto 
microscope slides, dried, and stored at 4°C until further use. 
The specimens were outlined on the slides with a Pap Pen to prevent 
the spilling of liquids. The blocking procedure was done with 3% donkey-
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serum in PBS containing 0.2% Triton for 1.5 h. After that, primary antibodies 
were added over night at 4°C and the specimens were stored in a moist 
chamber. Subsequently, the sections were rinsed three times with PBS and 
further incubated with the corresponding fluorophore-labeled secondary 
antibodies (diluted 1:500 in PBS) for 60-90 minutes in a dark humid 
chamber. Specimens were rinsed with PBS three times and cell nuclei were 
counterstained with Hoechst 33342 staining solution (0.75 µl/ml PBS) for 3 
min. After carefully rinsing with PBS, specimens on microscopy slides were 
covered with mounting medium and cover slips, which were sealed to the 
slides with nail polish. Images were captured using fluorescence 
microscopes. 
 
3.4. Molecular biology 
3.4.1. RNA Isolation 
 
Isolation of RNA was performed with the “Rneasy Mini Kit” (Qiagen) 
followed by treatment with RNase-free DNase according to the 
manufacturer’s manual. In this procedure, RNA is bound to a silica gel 
membrane and washed several times to remove contaminants and enzyme 
inhibitors before elution.  
For determining RNA concentration, absorbance was measured at 
260 nm. At this wavelength, absorption of 1 corresponds to a concentration 
of 40 µg/ml. To find out the extent of potential contaminations, absorbance 
was also measured at 230 and 280 nm. For a pure sample, the ratio of 
absorption at 260 and 280 nm should be greater than 2.0, whereas the ratio 
of absorbance at 260 and 230 nm should be greater than 1.7.  
 
3.4.2. DNA isolation 
 
To isolate genomic DNA (gDNA) from Th-Gfp mice, the end of the tail 
was cut off and stored if necessary at -80°C. DNA was isolated with DNeasy 
Blood and Tissue Kit according to the manufacturer’s manual. In short, the 
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tissue was lysed using Proteinase K and after appropriate buffering the DNA 
was adsorbed at a silica-based membrane in the presence of high 
concentrations of chaotropic salt, which remove water from hydrated 
molecules in solution. 
During centrifugation, DNA was selectively bound to the membrane 
as contaminants passed through. Remaining contaminants and enzyme 
inhibitors were removed in two efficient wash steps and DNA was finally 
eluted in water and stored at -80°C. 
 
 
3.4.3. Genotyping (TH) 
 
Genotyping PCR was done to assure the correct genotype of Th-Gfp 
animals. A positive control, a negative control and sample DNAs were 
included into the analysis. 
For one sample, the following pipetting scheme was used: 
 
 
Table 1: Pippeting scheme used for Genotyping PCR. 
 
 10x Taq Buffer   2.5 µl 
 5x Taq M Enhancer  2.5 µl 
 2mM dNTP’s   2.5 µl 
 Forward primer   1 µl 
 Reverse primer   1 µl 
 Taq Polymerase  0.7 µl 
 gDNA    4 µl 
 Ultra-Pure Water  10.8 µl 
 
 Total    25 µl 
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The following PCR programme was used to amplify the gDNA fragments: 
 
Table 2: Cycling protocol used for Genotyping PCR. 
 
 Step1  2’  95°C 
 Step2  30”  94°C 
 Step3  30”  56°C 
 Step4  45”  72°C 
 Step 2 to 4 were repeated 35 times. 
 Step5  10’  72°C. 
 
 
Agarose gel electrophoresis confirmed a fragment of 450 bp for Th-
Gfp-positive animals. Samples from Th-Gfp-negative animals did not display 
a fragment. 
 
 
3.4.4. Quantitative real-time reverse transcription PCR 
 
Quantitative real-time reverse transcription PCR (qRT-PCR) is the 
most sensitive and reliable procedure for gene expression analyses. Its wide 
dynamic range makes qRT-PCR the method of choice for the simultaneous 
quantification of both rare and abundant genes in the same sample.  
QRT-PCR was performed with the “Brilliant® SYBR® Green QRT-PCR 
Master Mix Kit” (Stratagene) according to the manufacturer’s manual. The 
method is based on the principle that fluorescent dye SYBR Green 
fluoresces when bound to double-stranded DNA. In the following, the 
fluorescence response can be monitored in a linear fashion as PCR product 
is generated over a range of PCR cycles. Relative concentrations of DNA 
present during the exponential phase of the reaction are then determined by 
plotting fluorescence against cycle number on a logarithmic scale. A 
threshold for detection of fluorescence above background is defined, 
whereas the cycle at which the fluorescence from a sample crosses the 
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threshold is called the threshold cycle, Ct. This value was used for the 
analysis of gene expression. 
1 µl (approximately 200 ng) of total RNA was reverse transcribed and 
subsequently amplified using 0.5 µM of both sense and antisense primer. 
After amplification, melting curves of the qRT-PCR products were acquired 
to demonstrate product specificity. The following cycling protocol was used: 
 
 
Table 3: Cycling protocol used for quantitative qRT-PCR 
 
Cycles Duration Temperature Procedure 
1 25 min 50°C first-strand cDNA synthesis 
1 15 min 95°C 
initial denaturation of cDNA 
/activation of DNA polymerase 
15 sec 95°C denaturation of DNA 
20 sec 60°C binding of primers to DNA 
35 
30 sec 72°C 
elongation of  primers to synthesize 
complementary strand 
1 1 min 95°C denaturation of PCR products 
1 30 sec 55°C 
annealing of PCR products to 
generate dissociation curves 
 
The results were expressed relative to the housekeeping gene Hmbs 
(hydroxymethylbilane synthase), whose expression did not vary under the 
experimental conditions used. Quantification was performed using the 
formula of the comparative threshold cycle (∆∆Ct method) 2^ (Ct 
[housekeeping gene] - Ct [target gene]) described by Livak et al.(102). 
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3.5. Other methods 
 
3.5.1. Cell counting and statistics 
 
For quantification of the percentage of cells producing a given marker 
a total of 100 to 1000 cells were counted per marker and the number was 
determined relative to the total number of DAPI-labeled nuclei. Statistical 
comparisons were made by Dunnett’s t-test and ANOVA. If data were not 
normally distributed, a non-parametric test (Mann-Whitney U-test) was used 
for comparisons of results. All data were presented as mean ± SEM. 
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4. Results 
 
4.1. Characterization of neural progenitor cells 
 
Tissue-specific stem cells are a suitable model for studying stem cell 
behavior and exploring the potential of stem cells for their application in 
regenerative therapies. They have never been reported to retain tumorigenic 
potential and are able to generate neurons and glia after cultivation in vitro. 
To investigate the regenerative potential of mouse fetal neural progenitor 
cells (NPCs) their characteristics were studied in detail and the signaling 
cascades involved in their in vitro differentiation were explored. 
Dopaminergic neurons arise from embryonic day (E) 10.5 to E12.5 in 
the mouse embryo. Fetal NPCs were isolated from time-mated C57Bl/6 mice 
at E10, E12 and E14 to explore differences in the dopaminergic potential of 
in vitro NPCs. They were subsequently grown as a typical neurosphere 
culture and as a monolayer on Poly-L-Ornithin/ Fibronectin coated dishes for 
at least 8-12 weeks prior to experiments. 
E14 fetal mouse NPCs were characterized by assessment of their 
morphology, a neurosphere forming assay and existence of diverse neural 
and stem cell markers on mRNA as well as protein levels (Fig.3). The 
morphology of cells in neurosphere cultures was round and a typical 
neurosphere contained 20 to 200 cells, while cells in adherent culture 
appeared mostly spindle-like as other adherent cell cultures (Fig. 3A). Cells 
in the middle of spheres were frequently differentiated or apoptotic, probably 
due to limited access to growth factors as reported by Svendsen and Smith 
(172). In adherent cultures only very few cells displayed protrusions or 
branched extensions showing a differentiated phenotype. It was important to 
re-plate monolayer NPC cultures as soon as sub-confluent status was 
reached, because the morphology of some cells appeared to change in 
cultures with a high density towards differentiated phenotypes. 
A neurosphere forming assay was performed for E14 suspension 
culture NPCs demonstrating that in a typical experiment 75 cells were 
necessary to form one neurosphere (Fig. 3B). The outcome of this 
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experiment varied strongly, because dilution series were very sensitive to 
personal errors and the survival of the cells was indirectly proportional to the 
length of remaining at room temperature. Cultures were usually terminated 
at 6 to 12 months, but at that time no drastic slowing of the cell-cycle or 
obvious phenotypic changes were observed by means of re-plating 
frequency of the culture. It has previously been shown that fetal cells could 
be cultured for up to 120 days in serum-free medium with a logarithmic 
increase in cell number and no evidence of gross chromosomal abnormality 
(105). 
QRT-PCR data demonstrated high expression of the stem cell marker 
Nestin (92) and epidermal growth factor receptor (Egf-R) in adherent culture 
compared to suspension culture (3.4±1.7 compared to 0.4±0.2 (p≤0.01, n=6) 
and 2.5±0.98 compared to 0.6±0.44 (p≤0.05, n=4) relative to the 
housekeeping gene HMBS) of E14 midbrain NPCs (Fig. 3C). The neural 
marker Tuj1 was expressed at low levels compared to the housekeeping 
gene (<1), however more prominent in suspension than in adherent NPCs 
(0.46±0.23 compared to 0.22±0.07; p≤0.05, n=4). Th (tyrosine hydroxylase) 
mRNA as a marker for dopaminergic neurons was not present in either 
culture. The glial markers Gfap (glial fibrillary acidic protein) and MBP 
(myelobasic protein) were expressed at low levels compared to the 
housekeeping gene (<1) in both NPC cultures. Suspension culture cells 
contained significantly more mRNA for the stem cell markers Sox-2 (4.1±1.3 
compared to 1.8±0.4; p≤0.01, n=4), Musashi (Msi; 1.3±0.35 compared to 
0.4±0.05; p≤0.05, n=4) and Prominin (Prom; 0.62±0.47 compared to 
0.08±0.03, p≤0.05, n=4), whereas Nkx2.2 (a marker for neuroepithelial 
neuroblasts) and Ngn-2 (marker for ventricular zone (VZ)/ subventricular 
zone (SVZ) progenitors) were transcribed at higher levels in adherent NPCs 
(4.2±1.5 compared to 1.0±0.3 (p≤0.05, n=4) and 0.14±0.02 compared to 
0.09±0.03 (p≤0.01, n=4), respectively). Equally transcribed in both cultures 
were Otx2 (VZ/SVZ progenitors) and En1 (ventral midbrain dopaminergic 
precursors) at levels equitable to the housekeeping gene. Otx1 
(neuroepithelial neuroblasts), Aldh1a1 (VZ/SVZ progenitors) and En2 
(ventral midbrain dopaminergic precursors) were equally transcribed, but at 
low levels (<1) compared to the housekeeping gene. FoxA1 and Nr4a2 
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(ventral midbrain dopaminergic precursors), as well as FoxA2 and Lmx1a 
(VZ/SVZ precursors), and Msx1, Lmx1b and Pitx3 (ventral midbrain 
dopaminergic precursors) were not expressed at all (Fig. 3C). QRT-PCR is 
a very sensitive method that produced variable results, especially for mRNA 
that was very low or high abundant compared to the housekeeping gene of 
use. Alternative housekeeping genes (β-Actin, Gapdh) were used, but they 
 
 
 
Fig. 3 Characteristics of E14 fetal mouse NPCs. A: Brightfield images of suspension and 
adherent NPCs. Scale bar: 50 µm. B: Neurosphere forming assay. The fraction of negative 
wells (no neurosphere formation) is shown versus initially plated cell number. Linear 
regression allows theoretical calculation of cells needed to form a neurosphere (at 0.37 of 
fraction of negatve wells). C: qRT-PCR of suspension (black) and adherent (white) NPC 
culture. D: Immunocytochemistry of E14 suspension (left panels) and adherent (right 
panels) NPCs. Scale bar: 50µm. E: Quantitative analysis of immunocytochemistry data of 
E14 suspension (black) and adherent (white) NPCs. Data are expressed as mean ± s.e.m. 
# - p≤0.05, ## - p≤ 0.01.  
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varied strongly in samples of different brain areas and NPC types and were 
thus excluded from analysis. 
Adherent E14 NPC cultures were almost completely (96±1.7%) 
positive for the neural progenitor marker Nestin, whereas only 84±4% of the 
suspension culture total cells expressed Nestin (Fig. 3D, E) confirming qRT-
PCR data. 
In both cultures about 36±10% of the cells stained for the proliferative 
marker Ki-67, and after incubation with BrdU for 20 h the same amount of 
cells were positive for BrdU, suggesting that the proliferating part of the 
culture (Ki-67-positive) doubled in 20 h (BrdU-positive) in adherent as well 
as suspension NPCs (Fig. 3D, E). Interestingly, not all cells that were Ki-67-
positive were also BrdU-positive and not all BrdU-positive cells were Ki-67-
positive. This suggested that asymmetric cell divisions producing one 
progenitor and one cell becoming post-mitotic were going on in the cultures. 
However, this observation was at least partly veiled by proliferating daughter 
cells that at the time of fixation were residing in the early G1-phase of the 
cell cycle, staining for BrdU but not for Ki-67, suggesting symmetric 
divisions.  
The amount of Gfap-positive cells varied strongly under both culture 
conditions between 10 and 40% of the total amount of cells (Fig. 3D, E). 
Astroglia appeared to be sentinel cells, the number of astroglia always 
correlated with a healthy look of an NPC culture (personal observation). In 
both cultures only few cells were positive for the postmitotic markers Dcx 
(0.5±0.3), Tuj1 (0.4±0.2), Map2ab (suspension NPCs: 0.9±0.6, adherent 
NPCs: 0.2±0.1) and GalC (suspension NPCs: 0.4±0.4, adherent NPCs: 0±0) 
(Fig. 3E). No cells stained positive for tyrosine hydroxylase (Th; data not 
shown).  
The characterization of long-term expanded E14 fetal mouse NPCs 
demonstrated that they were a rapidly dividing cell culture with a constant 
phenotype. They expressed the neural precursor marker Nestin and 
transcribed numerous markers of stem cells and neuronal development that 
marked them as a mixed culture of neuroepithelial, VZ/SVZ, and ventral 
midbrain committed progenitors. 
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E12 mouse suspension and adherent NPCs transcribed equally low 
amounts (<1 relative to housekeeping gene HMBS) of Nestin and Prominin 
(Prom) mRNA (Fig. 4A). Gfap and Egf-R mRNA were abundant in adherent 
NPCs but only present at low levels in suspension cells (0.5±0.44 compared 
to 0.05±0.01 (p≤0.05, n=6) and 2.5±0.38 compared to 0.09±0.03 (p≤0.01, 
n=5), respectively). Beta-III-Tubulin (Tuj1) mRNA was transcribed at a 
higher level in suspension NPCs (1.4±0.38 compared to 0.6±0.3; p≤0.05, 
n=5). Th, Nr4a2 and Pitx3 mRNA were not expressed in suspension or 
adherent E12 NPCs. Suspension and adherent E12 NPCs both expressed 
Nestin on the protein level (Fig. 4B,C), but adherent cells were almost 
completely (97±0.7%) positive, whereas only 83±5% of suspension cells 
showed Nestin immunoreactivity (Fig. 4B, C). E12 long-term propagated 
NPCs were negative for Th (Fig. 4C). In summary, fetal (E12) NPCs were a 
rapidly dividing population that displayed Nestin expression. Markers for 
 
 
Fig. 4 Characteristics of E12 fetal mouse NPCs. A: Relative mRNA levels of suspension 
(black) and adherent E12 fetal mouse NPCs. B: Nestin immunostain (red) of suspension 
(left panel) and adherent (right panel) NPCs. Nuclei were counterstained with DAPI (white). 
Scale bar: 50 µm. C: Quantitative analysis of immunocytochemical analysis of Nestin and 
Th in suspension (black) and adherent (white) E12 fetal mouse NPCs. Data are expressed 
as mean ±  s.e.m. # - p≤0.05, ## - p≤ 0.01. 
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dopaminergic differentiation (Th, Nr4a2 and Pitx3) were absent on the 
mRNA level.  
E10 suspension and adherent NPCs expressed Nestin mRNA but on 
a low level (<1 compared to the housekeeping gene HMBS). Interestingly, 
E10 NPCs transcribed fairly high amounts (>1 compared to housekeeping 
gene) of Prominin (Prom) mRNA. Adherent E10 NPCs expressed more Gfap 
and Egf-R mRNA than the suspension culture (1.5±0.9 compared to 0.2±0.1 
(p≤0.05, n=4) and 2.26±0.76 compared to 0.02±0.004 (p≤0.05, n=4) 
respectively) (Fig. 5A). They also displayed low levels (<1 compared to 
housekeeping gene) of Tuj1 mRNA. Th, Nr4a2 and Pitx3 mRNA were not 
transcribed in E10 mouse neural progenitors. E10 adherent NPCs were 
almost homogeneously (97±1%) positive for Nestin, whereas the suspension  
 
 
Fig. 5 Characteristics of E10 fetal mouse NPCs. A: Relative mRNA levels of suspension 
(black) and adherent E10 fetal mouse NPCs. B: Nestin immunostain (red) of suspension 
(left panel) and adherent (right panel) NPCs. Nuclei were counterstained with DAPI (white). 
Scale bar: 50 µm. C: Quantitative analysis of immunocytochemical results of suspension 
(black) and adherent (white) E10 fetal mouse NPCs. Data are expressed as mean ±  s.e.m. 
# - p≤0.05, ## - p≤ 0.01. 
 
culture harbored only 84±0.7% Nestin-positive cells (Fig. 5B, C). Again, 
adherent and suspension NPC cultures displayed the same amount 
(45±10%) of proliferating cells as shown by Ki-67 staining (Fig. 5C). BrdU 
was incorporated by 11±2% (suspension) and 14±2% (adherent) of the 
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cultures when added for 6h, suggesting a slightly higher proliferative 
potential than E14 NPCs. Gfap was expressed in varying amounts of cells in 
both NPC types. Map2ab (3±1%) and Dcx (2±1%) were rarely detected in 
both culture systems. Th immunoreactivity was not present (Fig. 5C). E10 
long-term expanded NPCs were a rapidly dividing cell population that was 
largely Nestin-positive and infrequently showed markers of differentiated 
neural cell types. Markers of dopaminergic differentiation were absent. 
The comparison of NPCs that were generated from three developmental 
stages (E10, E12, and E14) and cultivated in two different ways on the 
mRNA level demonstrated that Nestin mRNA production was highest in E14 
adherent NPCs and much lower at the other stages irrespective of their 
cultivation method (Fig. 6). Egf-R mRNA was higher in adherent cells 
compared to suspension cells from all embryonic stages. Prominin (Prom) 
was significantly expressed only in E10 NPCs and - to a lesser extend - in 
 
 
 
Fig. 6 Comparison of relative mRNA levels of NPCs from three different developmental 
stages (E14 (front), E12 (middle) and E10 (back)) and suspension (black, orange or blue 
bars) or adherent (white, yellow or light blue bars) culture conditions. 
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E14 suspension NPCs compared to other NPCs, suggesting that NPCs do 
retain at least some of their temporal identity in vitro. Amounts of Gfap 
mRNA varied strongly and were transcribed at equal levels in respect to the 
housekeeping gene only in E14 suspension and E12 adherent NPCs and 
were low abundant (<1 compared to housekeeping gene HMBS) under all 
other conditions. Tuj1 mRNA levels varied from low (<1) to normal (~1 
compared to HMBS) at E14 to E12, but were hardly detectable at embryonic 
day (E) 10. Th (tyrosine hydroxylase), Nr4a2, and Pitx3 mRNA were not 
transcribed in long-term expanded fetal mouse NPCs from any embryonic 
stages. 
In summary, long-term cultivated NPCs from embryonic stages E10 
to E14 are a self-renewing, rapidly dividing source of mixed progenitors that 
express Nestin and infrequently show markers for differentiated neural cells 
like Tuj1 (neuronal), Gfap (astroglial) and MBP (oligodendroglial) but not 
markers of dopaminergic differentiation as Nr4a2, Pitx3 or Th.  
 
 
4.2. Early differentiation of fetal mouse mesencephalic NPCs. 
 
Long-term cultivated NPCs displayed characteristics of a mixed 
stem/progenitor culture and had the potential to self-renew for a long period 
of time in vitro. To investigate whether they also retained the ability to 
differentiate into neurons and glia after prolonged periods in culture, the 
response to known factors important for dopaminergic differentiation was 
tested. E14 neural progenitor cells were expanded as a neurosphere culture 
in serum-free medium with mitogens Fgf-2 and Egf for at least 8 to 12 weeks 
prior to experiments. For differentiation experiments NPCs were plated on 
Poly-D-Lysine (PDL) coated cell culture dishes. Interleukin-1 (IL-1), 
Forskolin (a cAMP stabilizer), IL-1 and Forskolin, the combinations 
Fibroblast growth factor-8 (Fgf-8) and Sonic hedgehog (Shh) and Fgf-
8/Shh/Forskolin or no factors were added to serum-free medium. Early 
differentiation was assessed by qRT-PCR of key regulators of dopaminergic 
differentiation and by cell-based ELISA of critical signaling molecules 
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involved in dopaminergic differentiation of in vitro NPCs. At 3h after 
differentiation initiation a downregulation of Th mRNA was observed in IL-1, 
Forskolin and IL-1/Forskolin treated cultures (0.34±0.07 (p≤0.01, n=3), 
0.52±0.2 (p≤0.05, n=3) and 0.33±0.19 (p≤0.01, n=3), respectively) compared 
to control (no factors added), but not in Fgf-8/Shh and Fgf-8/Shh/Forskolin 
treated cultures (Fig. 7A). The orphan receptor Nurr1 (Nr4a2) was 
significantly upregulated after 3h only in IL-1/Forskolin treated cultures 
 
 
 
Fig. 7  Early differentiation characteristics of E14 fetal mouse NPCs. A: Relative mRNA 
levels of differentiated samples (no factor: white, IL-1 only: yellow, Forskolin only: green, IL-
1 and Forskolin: diagonal stripes, Fgf-8 and Shh: blue, Fgf-8, Shh and Forskolin: grey). B: 
Cell-based ELISA of activated signaling cascade molecule Erk1/2 in IL-1 treated 
differentiated samples. C: Cell-based ELISA of activated signaling cascade molecule p38 at 
3h of Control (CON = no factor), IL-1 and Forskolin (IL-1/F) and Fgf-8, Shh and Forskolin 
(Fgf-8/Shh/F) treated differentiated E14 fetal mouse NPCs. Data are expressed as mean ± 
s.e.m. # - p≤0.05, ## - p≤ 0.01.  
 
 
(4.44±0.41 (p≤0.05, n=3) compared to control (=1). Pitx3 mRNA was 
upregulated after 3h in IL-1, Forskolin and IL-1/Forskolin treated samples 
compared to control (1.87±0.02 (p≤0.01, n=3), 3.43±1.07 (p≤0.05, n=3) and 
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3.77±0.94 (p≤0.05, n=3), respectively). This early response may have been 
mediated by the activation of Erk1/2 and p38 MAPK signaling cascades. 
They were significantly upregulated by IL-1/Forskolin after 3h compared to 
untreated samples (Fig. 7B, C). Fgf-8/Shh/Forskolin did not lead to an 
activation of the p38 signaling cascade (Fig. 7C). 
In summary, after 3h NPCs respond to IL-1 and/or Forskolin-
mediated differentiation by activating Erk1/2 and p38 signaling cascades 
and transcription of the two key fate-determining factors for dopaminergic 
differentiation: Nr4a2 and Pitx3. 
 
4.3. Late differentiation of fetal mouse mesencephalic NPCs. 
 
Long-term cultivated NPCs had the potential to self-renew and 
respond to known factors involved in in vitro differentiation of dopaminergic 
neurons. Another hallmark of stem/progenitor cells is the differentiation into 
all three neural lineages after in vitro cultivation. To investigate the ability of 
long-term cultivated E14 NPCs to form neurons and glia, the cells were 
cultivated as neurosphere or monolayer cultures for at least 8-12 weeks 
prior to experiments, replated or plated on PDL-coated dishes and treated 
with no factors, IL-1/Forskolin or Fgf-8/Shh/Forskolin for in vitro 
differentiation. Late differentiation characteristics were monitored after 7 
days by qRT-PCR and immunocytochemical visualization of markers 
important for neural differentiation.  
After an interval of 7 days, differentiated suspension culture samples 
did not display Nestin mRNA transcription compared to NPCs (0.4±0.2; 
p≤0.05, n=3), irrespective of the factors used for differentiation (Fig. 8A). 
Pitx3 mRNA was significantly upregulated under control conditions 
(1.09±0.39; p≤0.05, n=3), IL-1/Forskolin treatment (1.55±0.15; p<0.01, n=3) 
and Fgf-8/Shh/Forskolin treatment (1.19±0.33; p≤0.05, n=3) compared to 
NPCs where Pitx3 was not expressed. Nr4a2 transcription was not 
significantly activated in differentiated samples after 7 days compared to 
NPCs. The neuronal marker Tuj1 was upregulated on the transcriptional 
level in control (0.73±0.13; p≤0.05, n=3) and IL-1/Forskolin samples in 
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suspension cultures (0.54±0.09; p≤0.05, n=3) compared to NPCs 
(0.27±0.09).  
In adherent NPCs differentiated by mitogen removal (no factor 
control, 0.07±0.03; p≤0.05, n=3) and IL-1/Forskolin treatment (0.10±0.04; 
p≤0.05, n=3) Nestin transcription was reduced after 7 days compared to 
NPCs (3.4±1.7) (Fig. 8B). Fgf-8/Shh/Forskolin treatment (0.62±0.36; n=2) 
did not lead to a significant reduction of Nestin mRNA levels. On the other  
 
Fig. 8 Characteristics of E14 fetal mouse NPCs after 7d of differentiation. A: Relative mRNA 
levels of differentiated suspension samples (no factor (control): white, IL-1 and Forskolin: 
diagonal stripes, Fgf-8, Shh and Forskolin: grey) relative to NPCs (black). B: Relative 
mRNA levels of differentiated adherent samples (no factor (control): white, IL-1 and 
Forskolin: diagonal stripes, Fgf-8, Shh and Forskolin: grey) relative to NPCs (black). Data 
are expressed as mean ±  s.e.m. # - p≤0.05 (to NPCs), ## - p≤ 0.01 (to NPCs), * - p≤0.05 
(to control), ** - p≤ 0.01 (to control). 
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hand only Fgf-8/Shh/Forskolin treatment (0.34±0.14; p≤0.05, n=3) led to an 
upregulation of Pitx3 mRNA after 7 days compared to NPCs as well as 
control (no factor) differentiated samples where Pitx3 was not expressed. 
Nr4a2 mRNA was not regulated at the 7 days timepoint in adherent cells. 
Tuj1 mRNA was upregulated in IL-1/Forskolin treated samples (1.19±0.4; 
p≤0.05, n=3) compared to NPCs (0.36±0.14) and in Fgf-8/Shh/Forskolin 
treated samples compared to NPCs (2.27±0.75 compared to 0.36±0.14; 
p≤0.01, n=3) as well as control differentiation (2.27±0.75 compared to 
0.6±0.2; p≤0.05, n=3). 
Immunocytochemistry revealed that adherent as well as suspension 
culture E14 NPCs differentiated into neurons (Tuj1, Map2ab), astroglia 
(Gfap) and oligodendrocytes (GalC) after removal of mitogens and plating 
on PDL-coated dishes (Fig. 9). E10 and E12 NPCs also differentiated into 
all three cell-types of the nervous system (data not shown). After 
 
Fig. 9  Differentiation characteristics of E14 fetal mouse NPCs. A: Immunocytochemistry of 
E14 suspension (left panels) and adherent (right panels) NPCs. Scale bar: 50 µm. B: 
Quantitative analysis of immunocytochemistry data of E14 suspension NPCs. NPCs: black, 
no factor (control): white, IL-1 and Forskolin: diagonal stripes, Fgf-8, Shh and Forskolin: 
grey. C: Quantitative analysis of immunocytochemistry data of E14 adherent NPCs. NPCs: 
black, no factor (control): white, IL-1 and Forskolin: diagonal stripes, Fgf-8, Shh and 
Forskolin: grey. Data are expressed as mean ±  s.e.m. # - p≤0.05 (to NPCs), ## - p≤ 0.01 
(to NPCs), * - p≤0.05 (to control), ** - p≤ 0.01 (to control). 
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differentiation of suspension culture NPCs the amount of Nestin-positive 
cells was significantly decreased in all samples (Fig. 9A, B). The reduction 
of Nestin expression was most apparent in control samples that underwent 
mitogen removal without additional factors: from 84±4% in NPCs to 18±6% 
in control. IL-1/Forskolin treatment resulted in 40±25% Nestin-positive cells, 
while Fgf-8/Shh/Forskolin resulted in 56±5% Nestin-immunoreactive cells. 
Gfap immunoreactivity was increased in differentiation control (36±1%) and 
IL-1/Forskolin (52±25%) compared to NPCs (10±4%). In IL-1/Forskolin 
treated samples significantly more Map2ab-positive (16±2%) cells were 
detected compared to NPCs (0.9±0.8%; p≤0.01, n=3) and to control (6±3% 
and 2±0.6%; p≤0.05, n=3) and significantly more Tuj1-positive (4±2%) cells 
were detected compared to NPCs (0.6±0.4%; p≤0.05, n=3). That is a 17-fold 
(Map2ab) and 7-fold (Tuj1) increase compared to NPCs and two-fold to 
control. Treatment with Fgf-8/Shh/Forskolin resulted in more Map2ab-
positive (9±2%; p≤0.01, n=3) cells compared to NPCs (0.9±0.8%). GalC-
positive cell numbers did not change significantly in suspension cultures. 
(Fig. 9A, B). 
In adherent NPCs Nestin was also detected in significantly fewer cells 
in all differentiated samples compared to NPCs (Fig. 9A, C). Control 
differentiation conditions yielded 55±22% (p≤0.05, n=3) Nestin-positive cells, 
IL-1/Forskolin yielded 38±15% (p≤0.01, n=3) and Fgf-8/Shh/Forskolin 
53±12% (p≤0.05, n=3) Nestin-positive cells. The number of Gfap 
immunoreactive cells did not change under differentiation conditions, 
whereas more GalC cells were present when adherent cells were treated 
with IL-1/Forskolin (3±0.6 compared to 0±0 in adherent NPCs). IL-
1/Forskolin and Fgf-8/Shh/Forskolin were effective for the generation of 
neurons; the substances yielded 8±2 and 6±2% Map2ab-positive cells 
respectively. Only the combination of IL-1/Forskolin led to an increase in 
Tuj1-positive cells (2.7±0.3%; p≤0.01, n=3) compared to NPCs (0.5±0.1%) 
(Fig. 9A, C). Suspension NPCs had a larger neurogenic potential than 
adherent NPCs. They yielded up to 16±2% Map2ab-positive cells in relation 
to the total cell number, whereas adherent cells generated a maximum of 
9±2% Map2ab-positive cells (Fig. 9B, C). All neurons generated from long-
term expanded cultures must have emerged in vitro because primary 
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neurons do not survive a long period in vitro. This is confirmed by the 
observation of shorter processes in long-term cultures than usually observed 
in primary cultures (data not shown).  
E10 and E12 fetal mouse NPCs were also examined for their 
potential to generate differentiated cell types. According to the procedure for 
E14 NPCs, E12 and E10 NPCs were grown for at least 12 weeks prior to 
plating onto Poly-D-Lysine cell culture dishes, differentiating with or without 
factors for at least one week prior to immunocytochemical analysis. Long-
term expanded E10 and E12 NPCs were able to generate moderate 
numbers (5-30%) of neurons (Tuj1) and glia (Gfap (30-70%) and GalC (less 
than 5% of total cell numbers) just as their E14 counterparts (Table 4).  
 
Table 4: Presence of differentiated cell types in differentiated NPCs of ontogenetically 
differently derived NPCs. +++ Well present in differentiated NPCs (30-70% of total cells), ++ 
moderately present in differentiated NPCs (5-30% of total cells), + somewhat present in 
differentiated NPCs (under 5%). 
 
 
In summary, E14, E12, and E10 NPCs generated the major cell types 
of the central nervous system after long-term expansion. E14 suspension 
NPCs had a larger neurogenic potential than adherent NPCs. On mRNA 
level, the neuronal marker Tuj1 and the dopaminergic marker Pitx3 were 
upregulated, whereas Nr4a2 showed no regulation at the 7d stage during 
differentiation of E14 NPCs. 
 
 
 
 E14 E12 E10 
Tuj1-positive cells ++ ++ ++ 
Gfap-positive cells +++ +++ +++ 
GalC-positive cells + + + 
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4.4. Neuron-specific differentiation of fetal mesencephalic 
NPCs. 
 
For the further characterization of the neurogenic potential of long-
term expanded NPCs the progenitor cultures were differentiated for 7 days 
and then subjected to immunocytochemistry of different neuronal markers or 
total RNA was isolated and qRT-PCR was performed for Th mRNA. 
Suspension NPCs did not transcribe significantly more Th mRNA compared 
to NPCs when differentiated (Fig. 10A). Adherent fetal NPCs generated Th 
mRNA when differentiated with IL-1/Forskolin (0.006±0.001; p≤0.01, n=3) in  
 
 
 
 
 
 
 
Fig. 10 Characteristics of differentiated E14 fetal mouse NPCs. A: Q (RT) PCR of Th mRNA 
in suspension (left) and adherent (right) culture. Differentiated samples (no factor: white, IL-
1 and Forskolin: stripes, Fgf-8, Shh and Forskolin: grey) are shown relative to NPCs (black). 
Data are expressed as mean ±  s.e.m. # - p≤0.05 (to NPCs), ## - p≤ 0.01 (to NPCs), * - 
p≤0.05 (to control), ** - p≤ 0.01 (to control) B-F: Immunocytochemistry of E14 suspension 
(left panels) and adherent (right panels) NPCs. Scale bar: 50 µm. G: Summary of markers 
present in long-term NPC cultures. 
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comparison to control (=0) and with Fgf-8/Shh/Forskolin (0.028±0.009; 
p≤0.05, n=3) in comparison to control (=0) as well as NPCs (=0) (Fig. 10A).  
E14 fetal mesencephalic NPCs did not have the potential to differentiate into 
dopaminergic, glutamatergic, GABAergic, serotonergic or cholinergic 
neurons after long-term cultivation (Fig. 10B-G). Neither suspension nor 
adherent culture NPCs showed positive stains for the neuronal markers 
suggesting that long-term proliferated fetal mouse NPC cultures did not have 
the potential to differentiate into neuronal subtypes. That could have been 
due to a relatively short differentiation procedure (7 days) that resulted in 
immature neurons, or the problem was the long expansion time in vitro. 
However many long-term proliferated and differentiated cells were positive 
for Map2ab, demonstrating a rather mature cell population after 
differentiation. Surprisingly, NPCs from E12 and E10 failed to differentiate 
into dopaminergic neurons just as their counterparts from E14 (data not 
shown). This finding suggested that the failure of E14 NPCs to generate 
dopaminergic neurons was not a developmental distinctiveness of NPCs. 
 
 
4.5. Short-term expansion of fetal mesencephalic NPCs. 
 
To determine whether fetal mouse NPCs lose their differentiation 
potential over long periods in vitro, E14 suspension NPCs were short-term 
proliferated (two weeks), subsequently differentiated and analyzed by 
immunocytochemistry. Fetal mouse NPCs displayed dopaminergic neurons 
(Th-positive) after short-term expansion and subsequent differentiation (Fig. 
11A, B). NPCs differentiated with IL-1/Forskolin (0.53±0.12%; p≤0.05, n=3) 
yielded more dopaminergic neurons than control (no factor differentiated) 
samples (0.22±0.06%) (Fig. 11A, B). Fgf-8/Shh/Forskolin treatment did not 
lead to significantly more dopaminergic neurons than in control conditions. 
IL-1/Forskolin samples (12.2±2.1%; p≤0.01, n=3) developed more Map2ab 
positive cells than control samples (3.2±0.9%) and stained for less 
progenitor (Nestin-positive) cells (22.8±5.6%; p≤0.01, n=3) than control 
samples (66.0±3.8%), whereas Fgf-8/Shh/Forskolin samples contained the  
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Fig. 11 Characteristics of differentiated fetal (short-term expanded) NPCs. A, B: 
Immunocytochemistry of E14 suspension NPCs differentiated with no factor (white), IL-1 
and Forskolin (diagonal stripes), Fgf-8, Shh and Forskolin (grey). Data are expressed as 
mean ± s.e.m. # - p≤0.05, ## - p≤ 0.01 (to control). Scale bar: 50 µm. 
 
 
 
same amounts of Map2ab (8.0±4.1%) and Nestin (66.0±4.5%) positive cells 
as control samples. The proliferative marker Ki-67 was present in 20-30% of 
total of cells, irrespective of the experimental condition (Fig. 11A, B). 
Short-term cultivation before differentiation did not allow excluding carry-
over of primary neurons from the isolation process, therefore other methods 
to demonstrate the in vitro generation of differentiated cell types were 
necessary. 
To show that the generated neurons and glial cells were de novo 
generated from proliferating cells, NPCs were labeled with BrdU immediately 
before differentiation (Fig. 12). NPCs were expanded for two weeks, 
incubated with 10 µM BrdU for 24 h to label all dividing cells, washed, 
allowed to regenerate in fresh medium and then differentiated. After one 
week of differentiation, the samples were immunocytochemically processed. 
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Rarely, oligodendrocytes (Fig. 12A) and astrocytes (Fig. 12B) were co-
labeled with BrdU, suggesting a cell division immediately before terminal 
differentiation. Dopaminergic neurons, glutamatergic neurons and 
GABAergic neurons were observed in short-term expanded NPCs (Fig. 12C,  
 
Fig. 12 Characteristics of differentiated fetal (short-term expanded) NPCs. A-G: 
Immunocytochemistry of E14 suspension NPCs that were labeled with BrdU and 
subsequently differentiated with no factor or IL-1 and Forskolin. Oligodendrocytes (GalC-
positive) and Astrocytes (Gfap-positive) were co-labeled with BrdU (arrows in A and B). 
Dopaminergic (Th-positive, C), Serotonergic (Ser-positive; D), GABAergic (GABA-positive; 
E) or Cholinergic (ChAT-positive; F) neurons were not co-labeled with BrdU. Glutamatergic 
(Glu-positive; G) neurons were rarely co-labeled with BrdU. Scale bar: 25 µm. 
 
E, G). No dopaminergic or GABAergic neuron also stained for BrdU (Fig. 
12C, E). However, glutamatergic (Fig. 12G) neurons were observed in the 
culture and sometimes also stained for BrdU. Not present in short-term 
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expanded NPCs from fetal midbrain were serotonergic and cholinergic 
neurons (Fig. 12D, F). 
These observations suggested that progenitors from the midbrain 
were regionally committed and were not able to form serotonergic or 
cholinergic neurons. Glutamatergic and GABAergic neurons were present in 
short NPC cultures, glutamatergic neurons being newly formed in vitro after 
cell division of precursor cells. Because they failed to incorporate BrdU, 
GABAergic and dopaminergic neurons could not have been formed before 
or at early time-points during differentiation. Presumably, cell division took 
place later in the differentiation phase, or not at all, suggesting terminal 
differentiation from committed precursor cells without cell division. Another 
possibility was that primary neurons carried over from the isolation process 
contaminated the experiments. BrdU-labeling during differentiation did not 
work because all neurons died during that process. It was therefore 
impossible to rule out formation of new neurons by cell division in the 
differentiation phase, yet this was not probable because cell divisions 
decreased rapidly during differentiation. To exclude carry-over of neurons 
from the isolation process, Th-Gfp mice were used. These mice carried Gfp 
in the tyrosine hydroxylase locus, thus all dopaminergic neurons appear 
green. After isolation of fetal mesencephalic tissue (E14), the cells were 
FACS-sorted, removing all Th-Gfp-positive cells (primary dopaminergic 
neurons) from the cell suspension (Fig. 13). During the sorting, dead cells 
were excluded by forward scatter analysis, and Gfp-positive cells were 
isolated from Gfp-negative cells (Fig. 13A). The Gfp-negative fraction 
contained 0.1% Gfp-positive cells (green frame; Fig. 13B). After this process 
the Th-Gfp negative fraction and a mixed NPC fraction were cultivated for 
one week, subsequently differentiated and analyzed by 
immunocytochemistry. In the mixed fraction the formation of dopaminergic 
neurons was evident (1.22% of total cell number) (Fig. 13C, D). 
Interestingly, in the Th-Gfp-negative fraction, also dopaminergic neurons 
were genereated (1.9% of total cell number) - more than contaminations of 
FACS sorting would amount to (0.1% of total cell number) (Fig. 13C, D). 
This ruled out the observation of contaminating primary neurons in short-
term expanded NPCs. Instead, dopaminergic neurons must have formed 
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Fig. 13  Characterization of short-term expanded NPCs. A, B: FACS-Sorting of isolated Th-
Gfp fetal mesencephalic NPCs. Th-Gfp negative fraction (Q4) contained 0.1% Th-Gfp-
positive cells (green frame). C: Immunocytochemistry of differentiated E14 NPCs from the 
Th-Gfp-negative fraction. Scale bar: 25 µm. D: Quantitative analysis of FACS sorted, 
proliferated, differentiated NPCs: Contaminations of primary cells after FACS sorting 
(black), differentiated Gfp-negative fraction (white), differentiated mixed fraction (grey).   
 
 
in vitro. In summary, Th-positive (dopaminergic) neurons were observed in 
short-term culture of fetal mouse NPCs, but they were not formed through 
cell division prior to or at early time-points of differentiation. Presumably, 
they formed from committed neural precursors without cell division. 
Additionally to Th-positive neurons, GABAergic and glutamatergic neurons 
were observed in short-term cultures. Only glutamatergic neurons formed 
through cell division. However, mouse fetal midbrain NPCs generated 
oligodendrocytes (GalC) and astrocytes (Gfap) through cell division of 
progenitor cells. 
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4.6. Comparison of short-term and long-term expanded 
NPCs. 
 
 
The failure of long-term expanded precursors to generate 
dopaminergic neurons on one hand and the existence of precursors that 
form dopaminergic neurons in the short-term expanded NPC culture on the 
other hand lead to the analysis of markers in NPC cultures at different 
stages of in vitro cultivation (Fig.  14). Total RNA was isolated from different  
NPC cultures and analyzed by qRT-PCR for the existence of markers 
thought to be involved in different stages of neuronal precursor 
development. Short-term expanded NPCs expanded for 14d and 21d only  
 
 
 
 
 
Fig. 14  Characteristics of E14 fetal mouse NPCs. Q (RT) PCR of suspension culture NPCs 
that were cultivated 14 d in vitro (white), 21 d in vitro (grey) and more than 80 days in vitro 
(black). Data are expressed as mean ± s.e.m. # - p≤0.05 (14d compared to 21d) , ## - p≤ 
0.01 (14d compared to 21d). * - p≤0.05 (14d compared to >80d) , ** - p≤ 0.01 (14d 
compared to >80d). + - p≤0.05 (21d compared to >80d) , ++ - p≤ 0.01 (21d compared to 
>80d). 
 
differed in their content of GFAP and MBP mRNA. GFAP mRNA was more 
abundant in the somewhat older culture (32±3 compared to 8±2 relative to 
HMBS; p≤0.01, n=4), whereas more MBP mRNA was determined in the 
younger in vitro cultures (105±17 compared to 44±28 relative to HMBS; 
p≤0.05, n=4) (Fig. 14). In comparison to >80 days (>80d) old NPCs short-
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term expanded NPCs (14d) contained more mRNA for the stem cell marker 
Musashi (Msi; 2.2±0.5 compared to 1.3±0.3; p≤0.05, n=4)), and the glial 
markers GFAP (8±2 compared to 0.36±0.11 relative to HMBS; p≤0.01, n=4) 
and MBP (105±17 compared to 1.1±0.9; p≤0.01, n=4). On the other hand, 
mRNA for stem cell markers Nestin (0.39±0.2 compared to 0.08±0.02 
relative to HMBS; p≤0.05, n=4), Sox-2 (4.1±1.3 compared to 1.0±0.5 relative 
to HMBS; p≤0.05, n=4), and Aldh1a1 (0.48±0.21 compared to 0.06±0.03 
relative to HMBS; p≤0.05, n=4) were more abundant in long-term expanded 
NPCs. Similarly, NPCs expanded for 21 days (21d) in vitro also transcribed 
more mRNA for the stem cell marker Msi (2.64±0.89 compared to 1.3±0.3 
relative to HMBS; p≤0.05, n=4) and the glial markers GFAP (32±3 compared 
to 0.36±0.11 relative to HMBS; p≤0.01, n=4) and MBP (44±28 compared to 
1.1±0.9 relative to HMBS; p≤0.01, n=4) than long-term expanded NPCs. 
Sox-2 mRNA was determined in higher quantities in long-term expanded 
NPCs (4.1±1.3 compared to 0.68±0.16 relative to HMBS; p≤0.05, n=4) (Fig. 
14). The controversial outcome mirrored the initial heterogeneity and 
ongoing change of the in vitro cultures.  
Equally transcribed in the different stage in vitro cultures were Otx1 
(neuroepithelial neuroblasts), Otx2 (VZ/SVZ progenitors), Nkx2.2 
(neuroepithelial neuroblasts), Ngn2 (VZ/SVZ progenitors) and Map2ab 
(neurons). Not transcribed at all stages were Msx1 and FoxA1 (ventral 
midbrain dopaminergic precursors) as well as FoxA2 (VZ/SVZ progenitors). 
Lmx1b (ventral midbrain dopaminergic precursors) was only transcribed in 
very early (14d) in vitro cultures (0.02±0.01 relative to HMBS), and Lmx1a 
(VZ/SVZ progenitors) was only transcribed in both early cultures (0.10±0.04 
and 0.07±0.05 relative to HMBS), not in long-term expanded NPCs.  
Combined, these data showed that a diversity of changes were going 
on and overlapping one another in in vitro NPC cultures. Importantly, 
markers of differentiated cell types (GFAP, MBP, Map2ab) stayed the same 
or went down, and markers for ventral midbrain dopaminergic precursors 
(FoxA1, Lmx1b) were absent or became absent over the course of NPC 
culture, suggesting an ‘aging’ effect of in vitro conditions. Markers for 
VZ/SVZ progenitors or neuroepithelial neuroblasts were transcribed variably 
in differently aged NPCs. 
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4.7. Existence of IL-1RI and IL-1 in vitro and in vivo at E 14. 
 
 
Interleukin (IL)-1 is a thoroughly investigated inflammatory cytokine 
involved in cellular activation and cell-to-cell communication. Besides its 
function in the immune system, a potential role as neuromodulator in the 
normal brain is emerging (181). It was shown that IL-1 is a potent inducer of 
a dopaminergic phenotype from fetal mouse as well as rat and human 
(26,101,136,159,160) mesencephalic precursors in vitro. The intracellular 
signaling cascades activated by IL-1 were p38 and Erk1/2 mediated. To 
investigate whether the effects were in vitro artifacts or whether IL-1 might 
play a role in the developing brain, the presence of IL-1 isoforms and the 
dominant and functional receptor IL-1RI in vitro and in vivo was established.  
Long-term suspension NPC cultures were used to detect IL-1α, IL-1β 
and IL-1RI in vitro (Fig. 15). Neurospheres were plated onto Poly-D-Lysine  
 
Fig. 15  Immunofluorescence of E14 long-term expanded NPCs for Interleukin (IL)-1α (A), 
IL-1β (B) and IL-1 receptor type I (C) in green counterstained with DAPI (white). Scale bar: 
50 µm. 
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coated culture dishes and left to adhere for 3h before fixation and 
subsequent immunofluorescence procedure. IL-1α, IL-1β and IL-1RI 
immunoreactivity was expected in the cytoplasm or plasma membrane of 
cells. IL-1α immunoreactivity was detected in all compartments of many but 
not all cells in long-term NPC culture (Fig. 15A). It was therefore assigned to 
unspecific binding of the antibody and regarded as not expressed. IL-1β 
immunoreactivity was observed mainly in the cytoplasm of body and 
processes in most cells (Fig. 15B). IL-1RI immunoreactivity was detected in 
the cytoplasm of the cell body in only few cells (Fig. 15C). IL-1β and IL-1RI 
were expressed in long-term NPC culture. The location of both proteins 
would have to be specified using confocal microscopy. The existence of a 
signal (IL-1β) and a transducer (IL-1RI) suggested a possible role in the in 
vitro differentiation of fetal NPCs.  
IL-1α, IL-1β, and IL-1RI immunoreactivity in vivo was assessed in 
brains of E14 mouse embryos (Fig. 16). Pregnant mice were perfused at 
E14, embryonic brains were dissected, quick-frozen, sectioned, and 
delivered to immunohistochemical analysis. Sections from midbrain regions 
of the brain were used. Images were obtained by classical fluorescence or 
confocal microscopy. No specific signal was obtained staining with the IL-1α 
antibody (Fig. 16A). It was assumed that no IL-1α immunoreactivity was 
present in the developing mouse midbrain. IL-1β immunoreactivity was 
present close to the ventricle in contrast to TUJ1 immunoreactivity, which 
occurred more laterally (Fig. 16B). The antibody for IL1RI apparently stained 
for vessels lacking other specific staining in the midbrain (Fig. 16C). It could 
be concluded that at least IL-1β was present in the developing mouse 
midbrain. 
In summary, long-term expanded fetal mesencephalic NPCs could be 
grown under suspension or adherent culture conditions and showed self-
renewing capacity as well as markers typical for NPCs. They could be 
differentiated into the three major cell types of the nervous system, but 
suspension NPCs had a larger potential to generate neurons than 
adherently grown NPCs. Signaling cascades involved in this process were 
activated by IL-1 and were p38 and Erk1/2 mediated. Long-term expanded 
NPCs did not have the potential to generate any neuronal sub-types. When 
 
70 
cultivated in vitro for short periods, fetal mesencephalic NPCs were able to 
generate dopaminergic neurons that probably did not arise through cell 
division, but differentiated from committed precursor cells. IL-1 and Forskolin 
were the most potent inductors of the dopaminergic fate. Glutamatergic  
 
 
 
 
Fig. 16 Immunohistochemical analysis of E14 brains (sagittal sections) for Interleukin (IL)-
1α (A), IL-1β (B) and IL-1 receptor type I (C) in green. Sections were counterstained with 
the neuronal marker Tuj1 (red) and DAPI (blue). Scale bar: 50 µm. 
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neurons were present in short-time expanded NPC cultures and were shown 
to be generated through cell division from progenitors. The precursor 
population of short cultures differed from long- term expanded cultures, 
suggesting an ‘aging’ effect of in vitro conditions. IL-1β was present inNPCs 
in vitro as well as close to the ventricular zone in vivo suggesting an 
expression in progenitor cells rather than differentiated cells. IL-1RI was 
expressed only in vitro, whereas IL-1α was not expressed in vivo or in vitro.  
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5. Discussion 
 
Neural stem (progenitor) cells (NPCs) from fetal tissue have been 
identified as a rapidly dividing source of cells that are able to generate cells 
of all three neural lineages and do not divide uncontrolled once transplanted 
into a host organism.  
Fetal mouse NPCs are a crucial tool for investigations on neural stem 
cell differentiation, because they make the employment of transgenic 
animals in vivo and cells in vitro possible. So far only short-term expanded 
NPC cultures were shown to display dopaminergic neurons and it was not 
clear whether this was due to real differentiation or a result of increased 
survival of primary dopaminergic neurons. 
The aims of the thesis were to characterize mouse fetal NPCs, to 
establish the long-term expansion of fetal mouse NPCs and the generation 
of dopaminergic neurons in long-term expanded fetal mouse NPCs, to 
investigate the signaling mechanisms involved in the differentiation of mouse 
fetal NPCs towards the dopaminergic phenotype and to compare NPCs that 
were cultivated for short periods in vitro with long-term expanded NPCs. 
 
5.1. Long-term expanded NPCs 
 
Mouse fetal mesencephalic NPCs were used to describe the self-
renewing and differentiation potential of mixed progenitor cultures. Long-
term expanded fetal mesencephalic NPCs could be grown under suspension 
or adherent culture conditions. In contrast to adult NPCs 
(48,130,131,141,152), fewer cells were needed to generate a neurosphere, 
showing the higher proliferative capacity of fetal NPCs. However, the 
neurosphere forming assay depended on the quick execution of the dilution 
series and was therefore variable in outcome. 
Adherently grown NPCs harbored 97% Nestin-positive cells in E14, 
E12, and E10 NPC cultures. Suspension culture NPCs had a smaller 
proportion of Nestin-positive cells which was probably due to the three-
dimensional shape of spheres. Nestin was the NPC marker of choice 
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because no better marker was available. However, Nestin is also expressed 
in different germ layers (154) and in postmitotic neural cells (32), its 
usefulness as a stem cell marker being therefore limited. Hence, other 
markers typical for NPCs were analyzed to monitor self-renewing capacity of 
the cultures such as Sox-2, Prominin, and Musashi1 (Msi), which were more 
abundant in suspension culture cells. This controversy compared to Nestin 
expression demonstrated that one marker rarely characterizes a cell type 
appropriately, that a combination of markers will define a true stem or 
progenitor cell (20). It also stressed that fetal NPC cultures were a 
heterogeneous source of progenitors as well as differentiated cells, because 
markers for differentiated neural cells were expressed, albeit at low levels or 
in few cells.  
Suspension NPCs transcribed Egf-R in much lower levels than 
adherent NPCs. Egf-R becomes expressed in development in a 
subpopulation of progenitors that previously acquired Egf responsiveness 
(21,87). Interestingly, according to the developmental change, Egf-R 
expression occurred on schedule (96) in suspension cultures (starting at 
E14) but not in adherent cultures, suggesting that cell-to-cell signaling is 
required. Since the higher transcription rate of Egf-R mRNA in adherent 
NPCs was observed from E10 (mostly Fgf-responsive cells) to E14 (Fgf- and 
Egf-responsive cells), the addition of both Fgf-2 and Egf may have lead to a 
higher Egf-R expression in adherent NPCs because regulatory elements 
may also require cell-to-cell contact.  
E14 NPCs were analyzed for the transcription of several markers 
known to be expressed in different populations of midbrain progenitors 
(20,157). Of neuroepithelial neuroblast markers both Otx1 and Nkx2.2 were 
present. Ventricular zone (VZ)/subventricular zone (SVZ) progenitor markers 
Otx2, Aldh1a1, and Ngn2 were present; Lmx1a and FoxA2 were not 
transcribed in E14 NPCs. Markers for ventral midbrain dopaminergic 
precursors were present in part: En1 and En2 were transcribed. On the 
other hand Msx1, Lmx1b, FoxA1, Nr4a2, and Pitx3 were not transcribed. 
This transcription profile suggested that a mixed population of progenitors 
was cultivated in vitro. It was also a hint that either certain markers for 
temporal and spatial origin were lost while others were maintained in vitro, 
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that progenitor populations (20) can be described with less markers than 
previously anticipated or that certain sub-populations of progenitors perish 
early in vitro. 
In E14 NPCs the same amount of cells was Ki-67-positive as well as 
BrdU-positive, when BrdU labeling was done for 20h in E14 NPCs. That 
meant that the proliferating part (Ki-67-positive) of the culture had doubled 
(BrdU) in the previous 20h. However, not all BrdU-positive cells were also 
Ki-67-positive and not all BrdU-positive cells were Ki-67-positive, suggesting 
that asymmetric cell divisions (known from the neuroepithelium in vivo) can 
also occur in vitro, generating one proliferating and one differentiating 
daughter cell - suggested also by Reynolds and Weiss (142). It must be 
noted, however, that Ki67 is absent in early G1-phase cells and in cells 
undergoing DNA repair (51,77). Cells staining for only BrdU therefore could 
also be proliferating daughter cells (suggesting symmetric divisions) that 
were residing in the early G1-phase of the cell cycle at the time of fixation.  
NPC cultures from different temporal origins (E14, E12, and E10) 
varied little, all expressed Nestin on one hand and no Th on the other hand. 
Most strikingly, E10 NPCs transcribed more Prominin mRNA than E12 and 
E14 NPCs, which was feasible since Prominin is regarded as a 
neuroepithelial stem cell marker (134). Therefore, the E10 NPC culture 
differed in an important characteristic from E12 and E14 NPCs, and one 
could conclude that at least part of the temporal identity was maintained in 
vitro, which is supported by Kim et al. who assumed as much using fetal 
human NPCs (79). 
E14 NPCs that were expanded for at least 8-12 weeks in vitro to 
obtain large quantities of cells for cell replacement strategies and to 
overcome contaminations of primary cells were successfully differentiated 
into the three major cell types of the nervous system – neurons, astroglia, 
and oligodendroglia. At an early stage of differentiation the transcription of 
Th mRNA was downregulated, whereas Pitx3 and Nr4a2 mRNAs were 
upregulated, when differentiation was induced by Interleukin- (IL-) 1 and 
Forskolin, factors known to stimulate in vitro dopaminergic specification 
(26,101,136,160). At the same time phosphorylation of the signaling 
molecules Erk1/2 and p38 was increased compared to control conditions. 
 
75 
The activation of those signaling cascades was an early answer to the 
exposition to IL-1 and/or Forskolin and might be involved in the 
dopaminergic specification of fetal mouse NPCs. Interestingly, factors known 
to be involved in the development of the midbrain (Shh and Fgf-8) did not 
lead to an increase of Pitx3 and Nr4a2 mRNA nor an increase in p38 
phosphorylation. Shh and Fgf-8 have been controversially discussed for 
their usefulness in in vitro differentiation of tissue-specific NPCs, and it might 
be the case that especially E14 NPCs are ontogenetically too old to be 
influenced by them (165), whereas ES cell-derived NPCs were successfully 
driven to adopt a dopaminergic phenotype (91). 
At a late stage (7d) of differentiation Nestin mRNA was mainly 
downregulated (significantly in control and IL-1/Forskolin treated adherent as 
well as all suspension cultures) compared to NPCs. On the protein level 
Nestin was expressed in fewer cells under all differentiation conditions 
compared to NPCs in suspension as well as adherent cultures and at the 
same time differentiation markers were expressed in more cells under 
differentiation conditions compared to NPCs. These results emphasized that 
the cultures responded to the removal of mitogens and plating on Poly-D-
Lysine with differentiation. The addition of differentiation cytokines or growth 
factors only intensified the effect.  
However, neuronal cell numbers were additionally regulated by 
incubation with cytokines or growth factors. Map2ab (mature neurons) cell 
numbers were higher in both culture systems when IL-1/Forskolin or Fgf-8/ 
Shh/ Forskolin were added compared to NPCs. More cells became Tuj1-
positive (immature neurons) when IL-1 and Forskolin were added in 
suspension as well as adherent cell cultures. Interestingly, suspension 
NPCs had a larger potential to generate neurons than adherent NPCs. A 
seemingly high number of progenitors in the NPC cultures (adherent) did not 
correlate with a high amount of neurons after one week of differentiation 
(suspension). These results suggested that the microenvironment of 
neurospheres contributed to the ability of NPCs to generate neurons. 
Schofield, who invented the ‘niche’ hypothesis, argued that stem cells only 
retained their pluripotency within an appropriate environment (151).  
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Long-term expanded NPCs did not have the potential to generate 
neuronal subtypes; most importantly, they did not generate dopaminergic 
neurons. Apparently, they differentiated into neurons but stayed in a 
postmitotic but uncommitted state. Because dopaminergic neurons in vivo 
arise at E10.5, potentially more adequate cell sources were isolated at E12 
and E10, but also failed to adopt dopaminergic phenotypes after long-term 
expansion in vitro. This was not resulting from short differentiation periods, 
since most neurons were Map2ab-positive (mature neurons) rather than 
Tuj1-positive (immature neurons). The loss of neurogenic potential in fetal 
mouse NPCs after long-term cultivation was species-specific, since neuronal 
subtype differentiation in vitro had been achieved in rat and human long-
term expanded progenitor cultures (26,101,107,136,159,160). Differences in 
proliferation and differentiation characteristics of NPCs of different species 
have already been reported previously (158,172). 
 
5.2. Short-term expanded NPCs 
 
When cultivated in vitro for short periods, fetal mesencephalic NPC 
cultures displayed dopaminergic neurons. The amount of Th-/Map2ab-
positive cells was significantly higher in IL-1/Forskolin treated cultures 
compared to control (no factors), but not in Fgf-8/ Shh/ Forskolin treated 
samples compared to control. Also, Map2ab-positive cells were more 
frequent in IL-1/Forskolin treated samples compared to control but not in 
Fgf-8/ Shh/ Forskolin treated samples in short-term expanded, differentiated 
NPCs. These findings support a previously established role for IL-1 in the 
dopaminergic specification of fetal NPCs (26,101,107,136,159,160). 
Compared to long-term expanded cultures, Map2ab-positive cell numbers in 
short-term cultures were lower due to a lower total cell number because of 
the shorter expansion time prior to differentiation, resulting in a lower cell 
density. It must be pointed out that the cell density of cultures has an 
extraordinarily strong effect on the presence of differentiation markers. An 
optimal cell density resulted in an overall healthier phenotype and more 
differentiated cells. It remained unknown whether these mechanisms 
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influenced all cell types in the culture or whether they influenced glia, which 
in turn secreted protective substances that supported neuronal cell types.  
The initial long-term expansion of NPC cultures was performed to 
ensure that primary neurons that contaminate early NPC cultures died or 
were highly diluted before the differentiation process began. In short-term 
expanded NPC cultures it was impossible to prevent that instead of 
differentiation the main process leading to a larger number of Th-positive 
neurons was neuronal protection. To monitor the formation of new neurons 
in vitro, short-term expanded NPC cultures were BrdU-labeled for 24h to 
include as many cells as possible into the analysis. No Th-/ Map2ab-positive 
cell was ever also BrdU-positive, suggesting that all dopaminergic neurons 
found had formed early during the in vitro cultivation, had formed without cell 
division from precursors or were surviving neurons from the midbrain 
isolation. It was unlikely that they had formed from a reliably expandable 
source of progenitors, because when cells are BrdU labeled and then divide, 
the dye is distributed to the daughter cells and they have a less intensive but 
visible stain, which could have been observed in Th+ neurons. It could not 
be ruled out though that the dopaminergic neurons formed during the 
differentiation process, because labeling during differentiation did not work 
since all cells died during that process. However, this was unlikely, because 
the removal of mitogens, plating onto Poly-D-Lysine and the addition of IL-
1/Forskolin resulted in a strong differentiation signal diminishing the amount 
of Nestin-positive cells and leading to a much lower amount of cells actively 
running the cell cycle. 
Differentiation after short-term expansion very rarely also lead to 
GABAergic and glutamatergic subtypes of neurons. In contrast to 
dopaminergic and GABAergic neurons which were not co-labeled with BrdU, 
glutamatergic neurons rarely displayed BrdU incorporation and were thus de 
novo generated. 
To find out whether fetal mouse NPCs were able to generate 
dopaminergic neurons in vitro, Th-Gfp mice were used. In this mouse, Gfp 
was expressed from the tyrosine hydroxylase locus and therefore all 
dopaminergic neurons appeared green. This was used to deplete the cell 
suspension of all dopaminergic neurons via FACS sorting prior to in vitro 
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cultivation. After subsequent short-time expansion and differentiation Th-
positive neurons were detected, proving that fetal mouse NPCs are able to 
generate dopaminergic neurons in vitro. Hence, those dopaminergic 
neurons formed most likely from precursors present at early stages of in 
vitro cultivation without cell division.  
The lack of dopaminergic neurons after long-term expansion 
therefore had to have been a consequence of the loss of progenitors able to 
generate dopaminergic neurons. It was not clear which factors were missing 
in vitro that would sustain those progenitors. Therefore, short and long-term 
NPC cultures were compared on the mRNA level for markers important for 
different precursor populations. As expected, precursor populations that 
were cultivated in vitro for two or three weeks differed from long-term 
expanded cultures. Markers of differentiated cell types stayed the same or 
went down and markers for ventral midbrain dopaminergic precursors that 
were tested were absent or became absent over the course of NPC culture, 
suggesting an ‘aging’ effect of in vitro conditions. There were a small 
number of genes that had a notable progress of transcription. MBP 
transcription is highest in very short expanded NPCs and lowest in long-term 
expanded NPCs. Lmx1a and Lmx1b are only transcribed at the two or one 
earliest stage(s) respectively. The markers resembling best the gradual loss 
of multilineage potential of in vitro NPCs are Musashi-1, (being highest in 
short-term cultures, decreasing in long-term suspension cultures and being 
lowest in adherent NPCs) and Nestin (antiproportional; its transcription goes 
up over cultivation time and increases over long-term suspension culture to 
adherent culture). These results further the doubts about Nestin alone being 
a sufficient stem cell marker, and at the same time put forward another 
known stem cell marker (Musashi-1) that might be better suited to describe 
multipotential fetal mouse NPCs. The most straightforward explanation for 
these observations would be that already after 14 days in vitro some 
markers were expressed abnormally. The data should be completed by a 
comparison with RNA from fetal midbrain tissue to find out if this expression 
profile was a result of in vitro artifacts. However, contributing to these 
findings was also the isolation of whole midbrain as a source for the stem 
cell cultures investigated here, leading to the cultivation of a heterogeneous 
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progenitor culture. Alternatively, these results account for a diversity of 
changes overlapping one another in in vitro NPCs or may also suggest that 
markers for different subpopulations of progenitors described in the literature 
are still not reliably identifying all progenitors. 
Another known factor for describing the potential of NPCs to self-
renew on one hand and differentiate on the other hand is the epidermal 
growth factor- receptor (Egf-R). Egf-R activity is associated with proliferation 
and survival of neural stem cells (10) and loss of Egf-R results in a failure of 
neuroepithelial precursors to differentiate, resulting in a severe reduction of 
the medial brain in the fruitfly (34). Additionally, it was shown that Fgf-2, but 
not Egf, supported Calcium-dependent self-renewal of NPCs and early 
expansion of lineage-restricted progenitors, whereas both growth factors 
together permitted the initial commitment of NPCs into neuronal and glial 
phenotypes (111). These findings might partly account for the failure of 
NPCs cultivated in vitro for long periods of time to generate neuronal 
subtypes, since they were cultivated with both mitogens. It has also been 
suggested that human recombinant forms of mitogens used for the 
proliferation can be more efficiently used by rat and human NPCs, possibly 
through higher affinities between ligand and receptor (158). 
The inflammatory cytokine IL-1 was shown to be an efficient inductor 
of the dopaminergic phenotype, therefore its expression and the expression 
of its major receptor was analyzed in vitro as well as in vivo to find out if 
cytokines might play a role in the normal, developing brain. IL-1β was 
present in NPCs in vitro as well as close to the ventricular zone in vivo 
suggesting an expression in progenitor cells rather than differentiated cells. 
IL-1RI was expressed only in vitro, whereas IL-1α was not shown to be 
expressed in vivo or in vitro. IL-1α is an isoform of IL-1β that binds the same 
receptors with lower affinity. It is thought to be an autocrine rather than 
paracrine effector and is generally studied in less detail (181). Both, IL-1α 
and IL-1β have been shown to equally induce a dopaminergic phenotype in 
in vitro cultures of fetal mesencephalic origin (26,101,136,160). Since only 
IL-1β was shown to be expressed in vivo, only IL-1β might have a function in 
vivo, with the transducing receptor unknown. The three-dimensional 
structure of the members of the human IL-1 family is composed of 12-14 β –
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strands (54,138,180). This β-barrel structure is closely related to that of 
fibroblast growth factor (121), which possesses some IL-1-like activities. 
This surprising relationship suggested that IL-1 might alternatively exert its 
function through one of the Fgf-receptors. 
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6. Conclusions and future prospects 
 
Several important conclusions concerning fetal mouse stem cell 
behavior could be drawn from the results of this work: 
Firstly, the results showed for the first time that in fetal mouse 
mesencephalic NPCs dopaminergic neurons differentiate from precursors 
(possibly ventral midbrain dopaminergic (DA) precursors; represented by 
orange circles) without cell division, therefore consuming those progenitors 
(Fig. 17). Therein fetal mouse NPCs differ significantly from rat and human 
NPCs or respond differently to the same in vitro conditions. Cultivation 
conditions need to be optimized for fetal mouse NPCs, which has been 
previously suggested (158,172). The differentiated cells (blue circles, Fig. 
17) die after some time in vitro, contributing to apoptotic cells and cell debris 
in the core of neurospheres also described by Svenden et al. (172).  
Secondly, less committed precursors (for example neuroepithelial or 
VZ/SVZ precursors, represented by white circles in Fig. 17) find 
 
Fig. 17 Schematic representation of the conclusions of this study. A neurosphere 
generated from fetal mouse midbrain NPCs consists of at least three cell types, ventral 
midbrain dopaminergic (DA) precursors (orange circles), other proliferating precursors 
(white circles) and differentiated or dead cells (blue circles) in the core of neurospheres. 
During the course of in vitro expansion, ventral midbrain DA precursors give rise to 
differentiated cells without cell division, thereby consuming this cell type. Other precursors 
proliferate but are not able to differentiate under the in vitro conditions tested. Differentiated 
cells eventually die. 
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appropriate conditions to proliferate but not to generate the more committed 
DA precursors that are able to generate dopaminergic neurons (possibly due 
to the effect of Egf and Fgf-2 (111)). 
Finally, the hallmarks of stem cells, self-renewal and multipotentiality, 
seem to be part of a delicate balance, that, when unsettled, goes in favor of 
one side without the possibility of returning to the previous status. The 
‘niche’ effect in neurospheres results in a better multipotentiality compared 
to adherent cultures, however, even in neurospheres the in vitro cultivation 
rapidly leads to the loss of dopaminergic potential. 
The results obtained in this project helped answer the questions: Can 
dopaminergic neurons be generated de novo from fetal mouse NPCs in 
vitro? Which signaling pathways/molecules are involved in the dopaminergic 
specification of fetal mouse NPCs? Do short-term and long-term NPCs differ 
from each other? 
Dopaminergic neurons can be generated de novo from fetal mouse 
NPCs in vitro. This was proven by eliminating all primary dopaminergic 
neurons from fetal midbrain cell suspensions prior to in vitro cultivation by 
FACS sorting of midbrain cell suspensions of Th-Gfp mice. Th-positive 
neurons developed also in the Th-Gfp negative fraction which was depleted 
of dopaminergic neurons. Other groups have failed to generate 
(dopaminergic) neurons from fetal mouse NPCs (31,83). It can be 
hypothesized that this was due to cultivation at atmospheric oxygen levels, 
because all other conditions were equal to those used here and cultivation at 
lowered (3%) oxygen conditions had been shown to be useful or necessary 
for the successful expansion and dopaminergic differentiation of rat and 
human NPCs (159,160,164,169). 
Erk 1/2 and p38 signaling pathways are probably involved in the 
dopaminergic specification of fetal mouse NPCs. They were activated in 
long-term expanded NPCs, which were not able to differentiate into 
dopaminergic neurons. However, these signaling cascades were activated 
immediately after the differentiation initiation by IL-1/Forskolin and it was 
shown that IL-1 and Forskolin were potent inductors of the dopaminergic 
phenotype in other cell types (26,74,101,160). This suggested that Erk 1/2 
and p38 were activated in order to differentiate towards a dopaminergic 
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phenotype but the cascade did not complete and the cells failed to adopt the 
dopaminergic phenotype. These experiments need to be repeated using 
short-term proliferated NPCs that are able to generate dopaminergic 
neurons to prove that Erk 1/2 and p38 are activated during the dopaminergic 
specification. 
Short-term and long-term NPCs differ significantly from each other 
suggesting an ‘aging’ effect of in vitro conditions. Importantly, markers of 
differentiated cell types (GFAP, MBP, Map2ab) stayed the same or went 
down from short-term to long-term expanded NPCs, and markers for ventral 
midbrain dopaminergic precursors (FoxA1, Lmx1b) were absent or became 
absent over the course of NPC culture. Two markers described the gradual 
loss of multilineage potential of in vitro NPCs: Musashi-1 (highest in short-
term cultures, decreasing over long-term suspension cultures to long-term 
adherent NPCs) and Nestin (antiproportional; its transcription goes up over 
cultivation time and increases furthermore from long-term suspension to 
adherent culture). These findings suggest that Musashi is a better marker for 
describing the multipotentiality of fetal mouse NPCs than Nestin. These 
results need to be confirmed on the protein level. The astrocytespecific 
glutamate transporter (GLAST) and brain-lipid-binding protein (BLBP) are 
markers that define radial glial cells - an embryonic cell type able to self-
renew and differentiate in vivo. It would be valuable to determine their 
expression in short as well as long-term NPCs to find out if they are also 
suitable to describe multipotential progenitors in vitro and to find out which 
marker expression must be sustained to support the multipotential capacity 
of fetal NPCs in vitro. 
The results of this project lead to the hypothesis that different brain 
size of an organism results in different margins for stem cell amplification. 
Fetal mouse NPCs therefore had a smaller margin in which they divide to 
produce proliferating offspring. This implicates that stem cells have an 
intrinsic timer for how long they generate progenitors and when they adopt 
more committed fates themselves and that they keep these cell-intrinsic 
information in vitro. It would be important to find out how to reconstruct this 
intrinsic memory towards a self-renewing and multipotential mouse fetal 
progenitor cell in vitro. 
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Further research should focus on two coherent issues: the isolation of 
more pure populations of progenitors and the more precise characterization 
of progenitor populations to find out which in vitro conditions need to be 
provided to keep the balance between proliferation and differentiation 
potential. The knowledge gained about stem cells this way would help 
establish cell sources for transplantation strategies. In practical terms, 
smaller parts of the developing midbrain should be isolated and analyzed for 
markers of progenitor cells before and during the course of in vitro 
expansion. Other growth factors should be added during the in vitro 
expansion, and/or mouse recombinant Egf and Fgf-2 should be obtained.  
Conditioned medium from suspension culture NPCs should be added 
to adherent NPCs to find out whether the higher neurogenic potential of 
suspension NPCs was a result of the microenvironment in neurospheres. 
Subsequently, factors that are responsible for this higher neurogenic 
potential in suspension NPCs should be identified. Conditioned media could 
also be employed to find out wether there is yet a way to stimulate long-term 
expanded NPCs to differentiate into dopaminergic neurons. 
At long sight, improved fetal mouse NPC cultures and their 
differentiated counterparts must be transplanted into parkinsonian animals to 
improve these NPCs as a transplantable cell source. 
Additionally, a possible signal transducer for IL-1 in vivo should be 
traced to further the knowledge on this effective dopaminergic agent. 
Long-term expansion of isolated fetal precursor cells is necessary to 
obtain cell numbers sufficient for transplantation strategies. Since long-term 
expanded NPCs were not able to differentiate into dopaminergic neurons, it 
is also necessary to discuss other ways to obtain NPC cultures with the 
potential to become dopaminergic neurons in sufficient quantities. One way 
that is starting to be discussed, is epigenetic reprogramming of more 
restricted neural progenitors into NPCs that are easily expanded and have a 
wider differentiation potential (37,68,80).  
The ultimate goal should be to establish a safe and reliably 
expandable cell source without tumorigenic potential that is able to 
differentiate into dopaminergic neurons and supporting glial cells. Such a 
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cell source would improve and support efforts at transplantion strategies for 
neurodegenerative diseases. 
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